From: <Windows Internet Explorer 7:n tallentama>
Subject: ELDD | Country profiles
Date: Mon, 5 Nov 2007 13:47:36 +0200
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_0000_01C81FB2.6C421910"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198

This is a multi-part message in MIME format.

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://eldd.emcdda.europa.eu/index.cfm?fuseaction=public.content&sLanguageISO=EN&nNodeID=5174

=EF=BB=BF<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" =
"http://www.w3c.org/TR/1999/REC-html401-19991224/loose.dtd">
<HTML lang=3Den xml:lang=3D"en" =
xmlns=3D"http://www.w3.org/1999/xhtml"><HEAD><TITLE>ELDD | Country =
profiles</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8">
<META content=3DNOARCHIVE name=3DROBOTS><LINK=20
href=3D"http://eldd.emcdda.europa.eu/public/cssSettings/default.css" =
type=3Dtext/css=20
rel=3DSTYLESHEET><LINK =
href=3D"/public/templates/genericTemplate/css/default.css"=20
type=3Dtext/css rel=3DSTYLESHEET><LINK media=3Dprint=20
href=3D"http://eldd.emcdda.europa.eu/public/templates/genericTemplate/css=
/hidenavigation.css"=20
type=3Dtext/css rel=3DSTYLESHEET>
<META content=3D"MSHTML 6.00.6000.16544" name=3DGENERATOR></HEAD>
<BODY id=3Dpage5174>
<DIV id=3Dheadersection>
<DIV id=3Dlogosection><A=20
href=3D"http://eldd.emcdda.europa.eu/html.cfm/indexEN.html"><IMG =
height=3D70=20
alt=3D"ELDD Home"=20
src=3D"http://eldd.emcdda.europa.eu/public/images/sites/eldd_logo_en.jpg"=
=20
width=3D299></A> </DIV>
<DIV id=3Dheadertools>
<UL id=3Dlanguagelist>
  <LI class=3Don>EN </LI></UL>
<FORM name=3Dsearch action=3D/index.cfm method=3Dpost><INPUT =
type=3Dhidden=20
value=3Dpublic.SearchResultsDisplay name=3Dfuseaction> <INPUT =
type=3Dhidden value=3DEN=20
name=3DsLanguageISO> <INPUT type=3Dhidden value=3Don name=3Dhtml> <INPUT =
type=3Dhidden=20
value=3Deldd.emcdda.europa.eu name=3DlSiteIDs>=20
<DIV id=3Dsearchtext>Search <INPUT size=3D12 name=3DsSearchText> <INPUT =
type=3Dimage=20
src=3D"http://eldd.emcdda.europa.eu/public/images/button.gif"> </DIV>
<DIV id=3Dadvsearch align=3Dright><A=20
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.Advanc=
edSearchFormDisplay&amp;sLanguageISO=3DEN">Advanced=20
search</A> </DIV></FORM></DIV></DIV>
<UL id=3Dnavbar>
  <LI><A =
href=3D"http://eldd.emcdda.europa.eu/html.cfm/index5173EN.html">Legal=20
  text search</A> </LI>
  <LI class=3Dcurrent>Country profiles </LI>
  <LI><A =
href=3D"http://eldd.emcdda.europa.eu/html.cfm/index5175EN.html">Legal=20
  reports</A> </LI>
  <LI><A =
href=3D"http://eldd.emcdda.europa.eu/html.cfm/index5036EN.html">Topic=20
  overviews</A> </LI>
  <LI><A =
href=3D"http://eldd.emcdda.europa.eu/html.cfm/index5176EN.html">News</A> =

  </LI></UL>
<DIV id=3Dbreadcrumbsanduserid>
<DIV id=3Dbreadcrumbs><SPAN id=3Dbreadcrumbstrail><A=20
href=3D"http://eldd.emcdda.europa.eu/html.cfm/index5029EN.html">ELDD</A><=
/SPAN> :=20
<SPAN id=3Dbreadcrumbscurrent>Country profiles</SPAN> </DIV>
<DIV id=3Dcurrentuser></DIV></DIV>
<DIV id=3Dcontentsection>
<DIV id=3Dleftsidebar>
<DIV id=3Dfurtheroptions><SPAN id=3Dfurtheroptionstitle>Further =
options</SPAN>=20
<UL>
  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A href=3D"http://www.emcdda.europa.eu/">EMCDDA =
home</A>=20
  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.SiteMa=
pDisplay&amp;sLanguageISO=3DEN">Sitemap</A>=20

  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.Advanc=
edSearchFormDisplay&amp;sLanguageISO=3DEN">Advanced=20
  search</A>=20
  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.html&a=
mp;sTemplate=3Dcontact&amp;sLanguageISO=3DEN">Contact=20
  us</A>=20
  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.html&a=
mp;sTemplate=3Dregister&amp;sLanguageISO=3DEN">Register=20
  with us</A>=20
  <LI><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dlogin.logout&=
amp;sSourceURL=3Dhttp%3A%2F%2Feldd%2Eemcdda%2Eeuropa%2Eeu%2F%3Ffuseaction=
%3Dpublic%2Econtent%26sLanguageISO%3DEN%26nNodeID%3D5174&amp;">Logout</A>=
=20

  <LI id=3Dprintpage><IMG height=3D11 alt=3D""=20
  src=3D"http://eldd.emcdda.europa.eu/public/images/arrow_on.gif" =
width=3D11=20
  border=3D0>&nbsp;<A=20
  =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?LayoutFormat=3Dprint">Prin=
t</A>=20
  </LI></UL></DIV></DIV>
<DIV id=3Dcontent-wrapper>
<DIV id=3Dcontent>
<DIV id=3Dtitlesection>
<H1>Country profiles</H1></DIV>
<DIV id=3Dmaincontent>
<FORM name=3Df1=20
action=3Dhttp://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conte=
nt&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174=20
method=3Dpost><INPUT type=3Dhidden value=3Deldd.countryprofiles =
name=3DpluginMethod>=20
<TABLE>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop width=3D"94%">
      <P align=3Dleft>Select the profile you wish to read: <SELECT=20
      onchange=3Dsubmit(); name=3Dcountry> <OPTION selected>Select =
Profile=20
        ...</OPTION> <OPTION value=3DEU>European Union</OPTION>=20
        <OPTION>-------------------</OPTION> <OPTION =
value=3DAT>Austria</OPTION>=20
        <OPTION value=3DBE>Belgium</OPTION> <OPTION =
value=3DBG>Bulgaria</OPTION>=20
        <OPTION value=3DCY>Cyprus</OPTION> <OPTION value=3DCZ>Czech=20
        Republic</OPTION> <OPTION value=3DDK>Denmark</OPTION> <OPTION=20
        value=3DEE>Estonia</OPTION> <OPTION value=3DFI>Finland</OPTION> =
<OPTION=20
        value=3DFR>France</OPTION> <OPTION value=3DDE>Germany</OPTION> =
<OPTION=20
        value=3DGR>Greece</OPTION> <OPTION value=3DHU>Hungary</OPTION> =
<OPTION=20
        value=3DIE>Ireland</OPTION> <OPTION value=3DIT>Italy</OPTION> =
<OPTION=20
        value=3DLV>Latvia</OPTION> <OPTION value=3DLT>Lithuania</OPTION> =
<OPTION=20
        value=3DLU>Luxembourg</OPTION> <OPTION value=3DMT>Malta</OPTION> =
<OPTION=20
        value=3DNL>Netherlands</OPTION> <OPTION =
value=3DNO>Norway</OPTION> <OPTION=20
        value=3DPL>Poland</OPTION> <OPTION value=3DPT>Portugal</OPTION> =
<OPTION=20
        value=3DSK>Slovak Republic</OPTION> <OPTION =
value=3DSI>Slovenia</OPTION>=20
        <OPTION value=3DES>Spain</OPTION> <OPTION =
value=3DSE>Sweden</OPTION> <OPTION=20
        value=3DUK>United Kingdom</OPTION></SELECT> </P>
      <P>Select language of profile: <A=20
      =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174&amp;pluginMethod=3Deldd.countr=
yprofiles&amp;country=3DAT&amp;language=3Dde"><IMG=20
      alt=3DDE=20
      =
src=3D"http://eldd.emcdda.europa.eu/plugins/eldd/images/languages/de.jpg"=
=20
      align=3Dbottom border=3D0></A>&nbsp; <IMG alt=3DEN=20
      =
src=3D"http://eldd.emcdda.europa.eu/plugins/eldd/images/languages/en2.jpg=
"=20
      align=3Dbottom border=3D0>&nbsp; </P>
      <TABLE width=3D"100%" border=3D0>
        <TBODY>
        <TR>
          <TD align=3Dleft><!-- Begin writing -->
            <P><!---=0A=
<meta http-equiv=3DContent-Type content=3D"text/html; =
charset=3Dwindows-1252">=0A=
<title>National review</title>=0A=
<style>=0A=
</style>=0A=
 --->
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D3><B>Country Profile - Austria</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><B><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c1">Development=20
            of legislation</A></B></FONT><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c1"><FONT=20
            face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B><BR></B></FONT></A><FONT=20
            face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><B><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c2">Controlled=20
            substances<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c3">Drug=20
            use and possession<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c4">Trafficking=20
            and drug-related crime<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c5">Prosecution=20
            and practice<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c6">Prevention,=20
            care and treatment <BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c7">Precursors<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c8">Money=20
            laundering and confiscation<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c9">New=20
            developments<BR></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c10">Links<BR></A><A=20
            name=3Dc1></A><A=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#c11">References</A></B></FONT>=
</P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Development of Legislation</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            first major Austrian drug law was issued in 1951: the =
=E2=80=98Narcotic=20
            Drugs Act=E2=80=99. This text was amended in 1971, 1974, =
1977, 1980,=20
            1985.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Already=20
            in 1971 the Austrian drug legislation marked a clear =
distinction=20
            between criminals trafficking in drugs and persons with =
drug-related=20
            health problems as a dividing criteria in the prosecution of =
drug=20
            related cases. Nine years later in 1980, an amendment to the =
law=20
            affirmed for the first time the principle that would become =
the=20
            basis of the drug policy in Austria: =E2=80=98therapy =
instead of=20
            punishment=E2=80=99. The drug addict is a sick person who =
commits drug law=20
            and acquisitive offences to compulsorily obey his addiction. =
He/she=20
            must have the possibility of being cared for instead of =
being=20
            punished.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>On 1=20
            January 1998, the =E2=80=98Narcotic Substances Act=E2=80=99 =
(Suchtmittelgesetz,=20
            abbr. SMG) entered into force to replace the Narcotic Drugs =
Act. The=20
            new law represents the continuation of the Austrian drug =
policy=20
            approach already traced by the previous drug legislation, in =

            particular, perceiving the principle of therapy instead of=20
            punishment. Therefore, it foresees severe sanctions for the =
act of=20
            sale or trafficking in narcotic drugs, now applied also to=20
            psychotropic substances and to precursors, while a range of =
measures=20
            are in place to treat and rehabilitate drug addicts who have =

            committed an offence. With this law Austria joins its =
European Union=20
            partners by adopting entirely the current UN Drugs =
Conventions not=20
            completely ratified until this new text, and putting under =
control=20
            the substances listed in tables III and IV of the 1971 UN =
Convention=20
            and precursors listed in table I and II of the <A =
name=3Dc2></A>1988=20
            UN Convention.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            name=3D_Toc514125333><B>Controlled =
substances</B></A></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>All&nbsp; substances as defined by law are listed =
in several=20
            schedules introduced by three decrees covering respectively: =

            </FONT></P>
            <UL>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
              size=3D2>narcotics (5 schedules); </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
              size=3D2>psychotropic substances (1 schedule); </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
              size=3D2>precursors (2 schedules).</FONT> </LI></UL>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Any=20
            substance to be officially designated as a controlled drug =
must be=20
            included in one of the relevant decrees. Following this=20
            classification, and with regard to possible sanctions and =
penalties,=20
            a distinction is made according to <A name=3Dc3></A>the =
nature of the=20
            substance when prosecuting drugs offences.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            name=3D_Toc514125334><B>Drug use and =
Possession</B></A></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>The&nbsp; consumption of controlled drugs is not =
mentioned as=20
            a specific offence by the Austrian law, however illegal =
possession=20
            of drugs is a crime. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>Austrian drugs law makes a distinction between =
possession of=20
            drugs for personal use and possession for trafficking. =
Criteria=20
            taken into account in practice when prosecuting to divide =
the two=20
            illegal acts are:</FONT></P>
            <UL>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>the=20
              quantity - small, large; </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>the=20
              frequency of use by the person =E2=80=93 =
occasional/regular; </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>the=20
              nature of the substance. </FONT></LI></UL>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>Therefore whoever acquires, possesses, produces, =
import,=20
            exports, delivers or supplies drugs to somebody or to a =
third person=20
            can be sentenced to up to 6 months<B> </B>of prison or to =
the=20
            payment of a fine of up to 360 times the daily unit fine =
(SMG art.=20
            27 para.1). However the person will be sentenced to up to =
three=20
            years of prison if he/she has put a minor in a position of =
using=20
            (consuming) a drug and he/she is an adult and 2 years older =
than the=20
            minor; if the crime was committed with commercial purposes, =
or if=20
            the person is member of a criminal band. If the author of =
these=20
            crimes is in a state of drug addiction and he has committed =
the=20
            above mentioned crimes with the sole purpose of obtaining =
the drug=20
            or the means for acquisition of a drug exclusively for his =
own=20
            personal consumption, the sentence will be only up to 6 =
months<B>=20
            </B>of prison or the payment of a fine of up to 360 times =
the daily=20
            unit fine. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Article=20
            28 (SMG) introduces&nbsp; the concept of =
=E2=80=9Clarge&nbsp; quantity=E2=80=9D, as=20
            dividing criteria between petty and serious offences. A =
decree<A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftn1"=20
            name=3D_ftnref1> [1] </A>adopted in 1997 introduced the so =
called=20
            =E2=80=9Clarge quantity=E2=80=9D for each drug expressed in =
terms of the pure=20
            substance such as: 20 g. of THC (active principle of =
cannabis), 5 g.=20
            of heroin, 15 g. of cocaine, 10 g. amphetamines, 30 g. MDMA, =
MBDB,=20
            MDE, etc. Recently an amendment to the law reduced the limit =

            quantity <A name=3Dc4></A>of heroin from 5 to 3 grams<A =
title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftn2"=20
            name=3D_ftnref2> [2] </A>.&nbsp;</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            name=3D_Toc514125335><B>Trafficking and drug related =
crime</B></A>=20
            </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>Offences under the SMG are production, acquisition, =

            possession, import, export, supply, and distribution of =
substances.=20
            It is the aim of the illegal act that determines its degree =
of=20
            punishment: for acquiring or possessing a large quantity of =
drugs=20
            with the intention of having it distributed the penalty will =
be up=20
            to 3 years; in case of production, import, export or =
distribution of=20
            large quantities of drugs, activities strongly connected to =
the=20
            concept of drug trafficking, the penalties will be up to 5 =
years=20
            (basic offence).</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>Penalties will be increased to between 1 and 10 =
years when=20
            the person acts commercially or as a member of a gang, and =
between 1=20
            and 15 years if he/she is a member of a gang with a previous =

            conviction for drug trafficking; member of a criminal gang =
of more=20
            than 10 people created to commit drug-trafficking offences; =
or in=20
            cases involving 25 times more than the 'large =
quantity'.&nbsp; If=20
            he/she is the leader of a drug-trafficking organisation, the =
<A=20
            name=3Dc5></A>sentence will be between 10 and 20 years or =
=E2=80=93 since an=20
            amendment to the Narcotic Substances Act of 8 May 2001, =
BGBl. I=20
            51/2001 - lifelong .</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Prosecution and judicial practice</B> =
</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Police=20
            have no discretion and must notify any offence discovered on =
duty.<A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftn3"=20
            name=3D_ftnref3> [3] </A>All criminal acts that Prosecutors =
learn=20
            about on duty have to be officially prosecuted, that means =
there has=20
            to be an official reaction. This can either be a diversion =
from=20
            prosecution or an official charge. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><U>Scenario 1: possession of heroin for personal =
use by an=20
            adult offender. </U></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>When=20
            questioned by the police the person admits to be a regular =
user of=20
            heroin and no other offences are involved. In this scenario =
the=20
            offender has acquired and possessed a small quantity of =
drugs for=20
            personal use, so the state prosecution, in accordance with =
Art.=20
            35(1) of the SMG asks the district authority as the =
competent health=20
            authority to give their opinion whether a health-related =
measure for=20
            the offender will be necessary. In addition the Austrian =
Drug=20
            Monitoring Agency (ANDMA), where a drug register with =
personal data=20
            is kept, is asked for information on the offender. =
</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>If=20
            according to the district authority it is necessary to adopt =

            health-related measures for the person in question, and if =
the=20
            offender is willing to undergo the necessary health-related =
measure,=20
            the state prosecution has to temporarily withdraw the report =
for a=20
            maximum probationary period of two years. Subsequently, the =
offender=20
            has to inform the state prosecution, at regular intervals, =
about the=20
            commencement and progress of the health-related measure, by=20
            submitting pertinent certificates; if such confirmations are =

            provided regularly, after the probationary period of two =
years the=20
            report to the police, which has been withdrawn temporarily, =
will be=20
            permanently withdrawn, in accordance with Art. 90(1) of the =
Code of=20
            Criminal Procedure (CCP). </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            proceedings will have to be continued if the offender =
persistently=20
            refuses to undergo the health-related measure or if a =
further=20
            criminal act is committed in connection with drug =
dependence. If =E2=80=93=20
            during the period of probation =E2=80=93 there is a new =
report of the=20
            police, because the offender has once more possessed or =
acquired a=20
            small quantity for personal use, the prosecutor can waive=20
            prosecution under certain conditions but he is no longer =
obliged to=20
            as for the first time (amendment BGBl. I =
51/2001).</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><U>Scenario 2: property crime committed by a drug =
user to=20
            finance her/his drug addiction </U>The offender has been =
previously=20
            convicted for drug-related crimes.&nbsp; He is now accused =
of having=20
            snatched a handbag without using considerable violence and =
the item=20
            stolen has not been very valuable, so the offence has not =
had=20
            significant consequences. The offender is addicted to drugs =
and has=20
            committed the robbery to finance his addiction. In this case =
the=20
            offence has been committed in connection with drug =
acquisition and=20
            the offender is faced with a prison sentence of not more =
than 5=20
            years. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>As the=20
            suspect has confessed to this offence, the report =
transmitted by the=20
            prosecuting authority (i.e. the police force) to the state=20
            prosecution is sufficient for direct indictment before a =
criminal=20
            court consisting of one judge and two lay judges, without =
further=20
            pre-trial investigations being carried out. This court =
sentences the=20
            defendant to one year of imprisonment because of a criminal =
offence=20
            under Art. 142(2) of the CC. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            sentence is suspended for a period of two years. The =
convicted=20
            offender commits himself to undergo the necessary =
health-related=20
            measure. The court will have to revoke the suspension of =
sentence=20
            and execute it if the convicted offender does not undergo or =

            continue treatment in the long run, or if he is convicted =
again in=20
            connection with his dependence on narcotic drugs and =
execution of=20
            the prison sentence seems to be necessary to prevent him =
from=20
            committing further offences.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><U>Scenario 3: small-scale distribution of drugs by =
a drug=20
            user to finance her/his drug addiction.<B> =
</B></U></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            offender is an adult previously convicted of drug-related =
offences.=20
            The suspect has confessed to selling heroin with a total =
gross=20
            weight of 150g and he is addicted to drugs. He committed the =
offence=20
            to finance his own drug dependence. Once again, as the =
suspect has=20
            confessed to the offence, the report transmitted by the =
prosecuting=20
            authority (i.e. the police force) to the state prosecution =
is=20
            sufficient for direct indictment before a criminal court =
consisting=20
            of one judge and two lay judges, without further pre-trial=20
            investigations being carried out. </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>This=20
            court sentences the suspect to two years of imprisonment =
without=20
            suspension for putting into circulation a large quantity of =
narcotic=20
            drugs according to Art. 28(2) of the SMG., and taking into=20
            consideration the previous criminal records for the same =
offences.=20
            However, according to Art. 39(1) of the SMG the court, as an =

            obligation, shall suspend execution of a prison sentence for =
a=20
            violation of the SMG for a maximum period of two years, if =
the=20
            prison sentence in question is less than two years and the =
convicted=20
            offender is dependent on drug consumption and commits =
himself to=20
            undergo the necessary health-related measures. If the =
convicted=20
            offender successfully undergoes the health-related measures =
during=20
            the suspension period the court shall then suspend the =
sentence and=20
            fix a probationary period of at least one year and at most =
three=20
            years. The court will have to revoke the suspension of =
sentence and=20
            execute it if the convicted offender does not undergo or =
continue=20
            treatment, or if he is convicted again in connection with =
his=20
            dependence on narcotic drugs and execution of the prison =
sentence <A=20
            name=3Dc6></A>seems to be necessary to prevent him from =
committing=20
            further offences.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Prevention, care and treatment</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2>Criteria such as =E2=80=98prevention of =
addiction=E2=80=99 and =E2=80=98substitution=20
            treatment=E2=80=99 were introduced for the first time in =
1997 in the=20
            Austrian drug law (SMG). In this context the options to =
divert=20
            drug-using offenders into treatment have been extended. =
</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            public prosecutor is obliged to suspend proceedings for a=20
            probationary period of two years if the person is charged =
with=20
            illegal acquisition or possession of a small amount of drugs =
for=20
            personal use. This is conditional on the opinion of the =
health=20
            authority that determines whether or not the offender needs=20
            health-related measures. However if, during the period of=20
            suspension, the person commits another crime foreseen in the =
same=20
            drug law, or a crime, by reason of his addiction, to obtain =
the=20
            drug, or if the person refuses to continue the therapeutic =
programme=20
            or the psychological counselling, normal prosecution takes =
over. If=20
            not, the case will be closed when the offender proves to the =
public=20
            prosecutor the successful conclusion of the programme. =
</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            public prosecutor may waive proceedings without having =
applied for=20
            the opinion of the health authority if a person is =
exclusively=20
            charged with acquisition or possession of a small quantity =
of=20
            cannabis for his own personal use and there is no doubt that =
no=20
            health-related measure is necessary, and if there has not =
been any=20
            report of the police concerning this person due to the same =
offence.=20
            </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>If the=20
            person has been prosecuted and sentenced for a drug law =
offence not=20
            higher than 2 years the court is obliged to suspend the =
execution of=20
            the sentence if the person shows his will to undergo the =
necessary=20
            therapeutic treatment. If successfully concluded the penalty =
has to=20
            be reviewed. From the interpretation of the law and the =
related=20
            orders, the therapeutic treatment is not only based on the=20
            abstention of the use of narcotics but also on substitution=20
            treatment. In the case of drug addicts (e.g. possession of =
small=20
            quantity of heroin for personal use) a treatment is ordered =
in about=20
            50% of the cases concerning adults (about 90% in cases =
concerning=20
            juvenile delinquents); in the other cases diversion is =
ordered=20
            without treatment under the condition of a 2 year probation =
<A=20
            name=3Dc7></A>period. The most commonly ordered treatment is =
medical=20
            surveillance.<A title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftn4"=20
            name=3D_ftnref4> [4] </A></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Precursors</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            bases of the control of trade, import, export and transit of =

            precursors are Regulation No. 3677/90/EEC as amended, and =
Directive=20
            92/109/EEC as amended. The provisions of Directive =
92/109/EEC were=20
            implemented into national law within the Austrian act on =
narcotics,=20
            psychotropic substances and precursors (Suchtmittelgesetz, =
SMG,=20
            BGBl. I Nr. 112/1997) as amended which entered into force on =
1=20
            January 1998, and within a national regulation on precursors =

            (Vorl=C3=A4uferstoffeverordnung, VorlV, BGBl. II Nr. =
376/1997), which=20
            also entered into force on 1 January 1998.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Under=20
            Art 21 of the SMG, substances may be confiscated if there is =
a=20
            violation of the requirements to avoid diversion to =
production of=20
            illicit narcotics and/or psychotropic substances. The penal=20
            provisions of the SMG also cover wholesale trafficking in =
precursors=20
            in Art 32, allowing for up to two years' imprisonment for =
purchase=20
            or possession of precursors with the knowledge that it will =
be used=20
            to manufacture large quantities of narcotics and/or =
psychotropic=20
            substances, and five years' imprisonment for manufacturing,=20
            importing, exporting or putting on the market a precursor, =
with=20
            similar knowledge. Breaches of licensing or documentation=20
            requirements may result in an administrative fine of up to =
&nbsp;36=20
            300.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            Federal Ministry of Social Security and Generations is =
competent to=20
            keep the drug register, where, based on a legal obligation =
on the=20
            part of the police and the courts to disclose relevant =
information,=20
            data are centrally stored about persons reported in =
connection with=20
            violations of the SMG, including infringements concerning =
the=20
            precursors covered by the SMG.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>The=20
            Federal Ministry of Social Security and Generations =
co-ordinates the=20
            legal aspects of precursors control. The Federal Ministry of =
Social=20
            Security and Generations is further responsible, in close=20
            co-operation with the Customs Authorities within the Federal =

            Ministry of Finance and the Police Authorities within the =
Federal=20
            Ministry of the Interior, for the control of the domestic =
and=20
            international trade in precursors. The Federal Ministry of =
Social=20
            Security and Generations issues licenses, registrations and =
export=20
            authorisations for precursors, and collects data for the =
annual=20
            reports on precursors to the European Commission and to the =
United=20
            Nations. The Police Authorities are responsible for =
investigation of=20
            illicit transactions involving precursors, and the Customs=20
            Authorities are responsible <A name=3Dc8></A>for the control =
of=20
            external trade in precursors. </FONT><BR></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Money Laundering and Confiscation</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Art.=20
            165 and 278a of the Austrian Penal Code (BGBl n=C2=BA =
60/1974 amended by=20
            federal law BGBl 527/1993 and BGBl I 153/1998 criminalise =
the=20
            laundering of all assets derived from serious offences - =
smuggling=20
            or evasion of import or export taxes (insofar as these fall =
within=20
            the competence of the courts) or disguising the origin =
thereof -=20
            particularly by giving false information in legal relations=20
            regarding the origin or true nature of those property items, =
etc.=20
            Such offences shall be liable to imprisonment for a term of =
up to=20
            two years or a monetary fine of up to 360 daily rates. =
Anyone who=20
            knowingly acquires such property items, keeps them in safe =
custody,=20
            invests, administers, converts, realizes or transfers them =
to a=20
            third party shall also be punished. Anyone who commits the =
act in=20
            respect of a value in excess of =E2=82=AC36 300 or as a =
member of a gang=20
            associated for the purpose of continuous money laundering =
shall be=20
            punished by imprisonment for a term of six months to five =
years.=20
            Anyone who, acting on the orders or in the interests of a =
criminal=20
            organization, appropriates, holds in safe custody, invests,=20
            administers, converts or turns to account parts of the =
assets of=20
            that organization, or transfers them to a third party, shall =
be=20
            punished by imprisonment for a term of up to three years or, =
if the=20
            act is in respect of a value exceeding =E2=82=AC36 300, by =
imprisonment for=20
            a term from six months to five <A name=3Dc9></A>years (art. =
278a para.=20
            2). </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><B>New=20
            developments</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Since 1=20
            June 2001 an amendment of the SMG is in force. The main =
provision=20
            included is an in&shy;creased penalty for (organised) drug=20
            trafficking up to lifelong imprisonment for leaders of =
criminal=20
            organisations in certain cases. Currently under discussion =
(since=20
            end 2000) is the legal framework for using cannabis for =
medical=20
            purposes. Already at the end of 1998, the Vienna City =
Council=20
            adopted a resolution on admitting cannabis for medical =
purposes by=20
            majority rule. In legal examination it was found that the =
SMG only=20
            prohibits all forms of consumption of the flowers and fruit =
of the=20
            plants belonging to the genus cannabis where the resin has =
not been=20
            extracted. The medical use of other cannabis products, =
however, is=20
            permitted. The decree on narcotic substances explicitly =
mentions=20
            delta-9-tetrahydrocannabinol, which is in pharmaceutical =
use, as a=20
            substance for which prescriptions may be issued (decree on =
narcotic=20
            substances, BGBl II 1997/374 annex IV). However, no =
pharmaceutical=20
            of this <A name=3Dc10></A>type has yet been admitted to the =
Austrian=20
            market.</FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>Links</B></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            name=3Dc11></A>A complete database of Austrian legislation =
is at <A=20
            =
href=3D"http://www.ris.bka.gv.at/bgbl/">http://www.ris.bka.gv.at/bgbl/</A=
></FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
            size=3D2><B>References</B> </FONT></P>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>Text=20
            revised by Mrs. Johanna Schopper</FONT></P>
            <UL>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
              size=3D2>Report concerning the system of the Austrian Drug =
Act 1997=20
              and the Austrian Drugs Strategy, Christian Schnattler, 20 =
October=20
              1999; </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>=C3=96BIG=20
              Reitox Austrian National Reports 1997- 2000; </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2>ELDD=20
              legal texts; </FONT>
              <LI><FONT face=3D"Verdana, Arial, Helvetica, sans-serif"=20
              size=3D2>Study on the legislation and regulation on drug =
trafficking=20
              in the European Union Member States, European Commission=20
              2001;&nbsp; </FONT></LI></UL>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><BR=20
            clear=3Dall></FONT></P>
            <HR align=3Dleft width=3D"33%" SIZE=3D1>

            <DIV id=3Dftn1>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftnref1"=20
            name=3D_ftn1>[1] </A>(see ELDD at <I>Verordnung der =
Bundesministerin=20
            f=C3=BCr Arbeit, Gesundheit und Soziales =C3=BCber die =
Untergrenzen einer=20
            gro=C3=9Fen Menge (Grenzmengen) bez=C3=BCglich der =
Suchtgifte=20
            (Suchtgift-Grenzmengenverordnung =E2=80=93 SGV=20
377/1997)</I></FONT></P></DIV>
            <DIV id=3Dftn2>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftnref2"=20
            name=3D_ftn2>[2] =
</A>=E2=80=9CGrenzmengenverordnung=E2=80=9D&nbsp; (BGBl. II=20
            145/2001)</FONT></P></DIV>
            <DIV id=3Dftn3>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftnref3"=20
            name=3D_ftn3>[3] </A><I>Foregger/Kodek</I>, StPO<SUP>7 =
</SUP>=C2=A7 34 Anm=20
            I.</FONT></P></DIV>
            <DIV id=3Dftn4>
            <P><FONT face=3D"Verdana, Arial, Helvetica, sans-serif" =
size=3D2><A=20
            title=3D""=20
            =
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.conten=
t&amp;sLanguageISO=3DEN&amp;nNodeID=3D5174#_ftnref4"=20
            name=3D_ftn4>[4] </A>Prosecution of drug users in Europe: =
varying=20
            pathways to similar objectives, EMCDDA 2001</FONT></P></DIV>
            <P></P><!-- End writing =
--></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></FORM></DIV>
<DIV class=3Dgroupboxes></DIV>
<DIV class=3Dattachments></DIV>
<DIV id=3Dfootersection>
<DIV id=3Dfooterlinks><A =
href=3D"http://www.emcdda.europa.eu/">EMCDDA</A> | <A=20
href=3D"http://eldd.emcdda.europa.eu/index.cfm?LanguageISO=3DEN">home</A>=
 | <A=20
href=3D"mailto:emcddawebmasters[a]emcdda.europa.eu">webmaster</A> | <A=20
href=3D"http://eldd.emcdda.europa.eu/index.cfm?fuseaction=3Dpublic.html&a=
mp;sTemplate=3Ddisclaimer&amp;sLanguageISO=3DEN">disclaimer</A>=20
</DIV>
<DIV id=3Dfooterprint><A=20
href=3D"http://eldd.emcdda.europa.eu/index.cfm?LayoutFormat=3Dprint">Prin=
t</A>=20
</DIV>
<DIV id=3Dlastupdate><A>Last change: Monday, 29 November=20
2004</A></DIV></DIV></DIV></DIV></DIV></BODY></HTML>

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://eldd.emcdda.europa.eu/public/images/sites/eldd_logo_en.jpg

/9j/4AAQSkZJRgABAgAAZABkAAD/7AARRHVja3kAAQAEAAAAUAAA/+4ADkFkb2JlAGTAAAAAAf/b
AIQAAgICAgICAgICAgMCAgIDBAMCAgMEBQQEBAQEBQYFBQUFBQUGBgcHCAcHBgkJCgoJCQwMDAwM
DAwMDAwMDAwMDAEDAwMFBAUJBgYJDQsJCw0PDg4ODg8PDAwMDAwPDwwMDAwMDA8MDAwMDAwMDAwM
DAwMDAwMDAwMDAwMDAwMDAwM/8AAEQgARgErAwERAAIRAQMRAf/EALYAAQABBAMBAQAAAAAAAAAA
AAQDBgcICQACBQEKAQEAAQUBAQAAAAAAAAAAAAABAgADBAUGBwgQAAEEAgIBAgUACAMECwAAAAIB
AwQFAAYRBxIhEzFBIhQIUWEyI7QVdjdxoRbSlRcJgUJSYtMkNEVWdxgRAAEDAgMEBgUHCwQDAAAA
AAEAEQIDBCExEkFRYQVxgZEiEwbwsTIUB6HB0UJisnNSgpKTs3QVNRY2COFyohdDU1T/2gAMAwEA
AhEDEQA/ANVefQa8tXMpUu6EiYJXdHET5LlMqUiPgnyXBlTpgKioip805TBSSB+WRSpxwSkjglIH
5YJSgyJSkhglKDIpSgwSlBkUpYYKSUGRSlhkSlLDBKWGRUksMilLDBKWGRKUsMClKDIlSSw+WRSl
BglKDIpSQwUkkMEpI5FKQOCpIHBKnHBKnHBKmTBKlTBK7+uCpaxs7Bc0uZSpfU9VROUTlfivwT/H
KSA6uH2D1lsPWpayGwP17y7XTR7ys+wlNyf/AC0lF8VP21Xj1RU/X8s5zy75oteeCsbeMx4NSVOW
qJj3o7n9BtWy5jyupY6PEIOuIkGL4FS6fadawtV3qJuGuzrbarGK03o9lFf9tiI8B+44UgfjwvgI
oo8qqESLwnrkOcWvNqt7azs60IUIyJrRkHlOJDAR6HMscHAIc4JsqtpCjUFaBMyO4QcBvf02lbbf
xI1/R0/GPVNl2LU6u1KC1bSbGa5WMzJRNMTpKqvq2Rn4gPonqvCcJnyf8XOY8xHm6vbW9epASNMR
AqShF5U4cREOT2r1jynb238JjVqU4ljIk6QThI8HV/Ou4/UvZmn0+66/oFSzU3TZFGCbSx2HUVsl
BxPE2kVUExUeU9FVF4zgPMFbnfJL6pZXF1UNSmcdNWUhiHGIltBBbPFdBy+Fle0Y1qdKOk74AdOz
eq2/4eaB/wDBtf8A92RP/DzTf1FzP/6q36yf0rN/h1r/AOqH6I+hal/zqp6ik7go4lLVQ6iIWpw3
TjQmG47ams2cimotiKKqoiJz8fRM+u/gNeV7vkNWdepKcveJh5EyLaKeDknDgvIvPtGnSv4iEREe
GMgB9aW5Yahnta4pKDIpSQwSlBkUpQYJSgyKUsMCpJYZFKWGRSlBgUpYZFSSwyKUsPlglLDIqSWG
RKUoMClLD5ZFKUGCUkMipJQYJSRwVJIZFSSBwSkDglTjgqU44JUw4JUo4Kl3ykrWNnXrmlI02rrr
bSGDaumII44SAA+S8ckRcIKJ81X4ZGctMSWJbdieobTwUox1EBV/2R1lsnVlxAo9oKCs6xrYtowE
KWzKRGZTYmPn7RF4qiqo+voXiqjyPC5z/lrzPaeYKE69qJ6YzlA6omOMCRg4D4MeDgFjgs/mXLKt
hMQqM5AOBBz6Oz1YLwdb1vbd/v63V9WqLLbNktXVCtp4YHJfcJfU1QfXhEROSJeERPUlRM3VSdG1
gZy0wiMzgB6bliQhUrSEQ5Ky53X8E+wOqdPj7l3J2ToHV0eZykKksp8yZYvuCiKTLEeBDke8Yoqc
o0pInzVE9c0lv5lo3VTw7enOfEAAdZJDda2NXlE6MdVSUY9ePyArMn8O+2Oo4vXetdNBvtdZbXAc
mthDkR5MJqekuU88IRvvWmkdLxcRFD4888IqeufLHxp8o84/i9fm8aEvdpCB1xIlo0QjEmYiTKIc
e0Q3FeoeTOb2YtI2hqDxHOB26iTg+B6M1nPIdYrokqUrBIzGByQ+1GaU3C8UUzUWm0UjJf0InKr+
vPB4RlWnGL4lgHLDcMTgB04Bd3IiESWwGOCovrbsnW+1tYZ27VFmFTvyH4zTsyM7GIjjuK2fgjgj
5JynxT0+XxRUzceYvLt3yC7Npd6RUABIjISwkHD6SWPA9OTLD5bzKlzCl4tJ9LkYgjLpWrb8/f70
0P8AR8L+On59Xf4+f2/V/eZ/s6S8p+IX8wh+GPvSWEg57ouGV55XRPaVdrLW3z9cZiUL9QxfMyHb
OtF466SwMpl8YqyvfVDaNDRPb8uF+Ga+PMreU/DEu87ZHMFmdmz4rKNpVEdRGDPmMu1WrDM1Y6UG
RSlBgUpYZFISgwSlBkSpKpKGguNjkTYtLCKe/X1821mNgQioQ69g5Up1fMh5RtpsiVE9fT0RVy1U
qxpgGRZyB1ksPlU4QMstz9iCGSKEsMipJYZEpVabPqkzU3aJqZJZklfUcC9jqz5cAzYNe622Xkif
UKei8en68x6NcVXbYSOxXalMwbiAe1Vra9J9pUNPIv7HT5P8phR25c+VFdYmLFjugLgOyAjOumyC
iSL5OCKeuY8OY29SWkSxOG0P0Pn1K7K1qRDkYK24ZmKylBkSlVjTavLuNf2zYmZDLUbUWYb01g/L
3HUmyRjAjfCKn0kXK8qnpmPUrCE4wOcn+QOrsYGUTLcvDDLqgkhkVIJQYFUkjgkJI5FKQOCkkDgl
TjgVSnHBKmHBKlHBUu+CVrGzsFzS58MpUkvSJk5wPfffnPqvi0hkTpqpkpeI8qq8kRKvCfFV/SuW
6dKnSDQiIjgANjbOAboCnKUpnEuv0i/ib+P+o/iH0fa9k9gR2ou+S6Ny+7HvHQE3q6Ey0sn+WR1+
KC0Ip5oK/vHf0ogInk/O+aVObXQpUvYdojectR6fkHWu35fZwsqOuftM54cPTatDHfneG2/kF2Td
9hbXJcQJTps63R+aqxV1okvsRWR+CKg8K4SJ9Z8kvxz0zlnLqdhQFKHWd52n6NwXI3t3O5qGUurg
j7P1fYa91Z1X23BddOq3Up8Sc6K8LDtIEx8W0Ah4UUcZbQh+aEB+vwzQct80UrznN9yioBroCEo/
bpVIR1PvMZkg/ZlHis255ZOhaUbuOUzIHhKJLdo9RW3D8M+9JfcfXkyh2qT99umi+1DtpbvClPgP
CSRpLif9Y+AJtxfmqIS+pZ8k/GTyNDy1zSNe1Gm2uHlED/xzi2uA3DEShuBYeyvW/JvPDzK2NOqX
qQwP2gcj8x7dqzCjxYsQFbiRmorZF5E2yAtipcInKoKInPCIn/RnkE6kqheRJPEv6118YRjgAy0/
/n7/AHpof6Phfx0/Psj/AB8/t+r+8z/Z0l458Qv5hD8MfeksJBz3RcKs1O9pOppWaTHkdXWdjsa9
UaL7W+t2khuI0v8ApyAoksIYxNqjY/SvLvr8fTOe5aKmqZFQCPi1O6wf2ztf5ltbsxaPcL6I4v8A
ZGxl7Oz9GajRbd3XGXXZkXW9b7D1mg0SS+9IRp2vtpklTBp4iT31citiYlyS+P1IvrzlujzKpOnS
OoajTlKWWcQOzFSqWkIznhgJADoJPbglWGkdSMvd0XlH1RZ38LqDYWdXhagxbzHHZYypk5srqzdb
T3G2WRiAyLbCJ+8dHzNfiRG5uT4UZVQDUjq1MMGA7seJd3OwYBSNKl3yIE6SzOd5xPY2G9VJfdNd
c6fp207wnV+xbLLYkahNj6HJsJDUigZ2CvnvyYlm5GaFw2wNhsmy8W3ODZ81TkxKzS5hWrVY0/Ej
Ed8amHe0EAGL7cS+YwPBTna04QM9BPs4PlqBwPoNiqpn8fOoqSoe2q1gOkV7YU0YNEvZV6krXxs6
eLZnGcPX6eweckGckgYWQ20PiHqDh+SJZPNLmctETkJd4CLSaRi/flENhixOeYVwWdKI1HaRgXwc
A/VBx3Oyp2N0z1vrt1pGuDomz9rRd+2y1pnNmZcmVEmrj19wda3G+xKOPhLRltJD4yUTgTEfFv8A
by6eYV6kZz1xp6IgthISeOp3f2XwGndtyUBa04mMdJlqJD4hmLZb9pderY9U9PQrbWdFTTpq3G6x
N7dZ2sLV9Fry1+3vI1crcUkJtz93XNg75r9Q+qeJ8ksIXtzKMqusNE08GGOqMDLH84spSt6QIhpx
OrF8mMm9SsZ+Prbj2z7s00BOuu9bbyDbQIpERFr05ERET1VVXNlzQtTh+JT++Fi2ftS/2y+6Vevq
3pjrqbomlWu6x3pFxvlvPrpQ+Ow/eVzUU22hCvi09PYNOylFz3vCUYoSKCIPiqmmuveYVo1Zxp5Q
AP1GL/lGUokR2d3j0LKt7WmYRMs5E/lYdDA49KVo/V3WA7P0notppl3vp9oODMst0hyn4KMNDaPw
zZYiCJIjcduN5SlcX3BQi49tRHkub2v4dapGYhowESAfqguTvL91sOlNK3p6oQMTLVty2tlw27VU
Gi9P9dyt56q0Ox64vtsh7403aWm7xJ8hhqODj74HHZbbbVv2YqM+2+RH7il5qJB9KLZub+sKVSqK
kYmGAiQNwx6S7jZ0qdG2pmcIGJOrF39MtqsP3J/6zrf/AOvNa/g0zZ2GVT8SXrWJc5x/2j1K/Y0+
4J+Tldf00WVCpKhNfl7XfutkFbHpm6uEtis14k9r2CYQxMSX6+fBEVVRM1niU/cDGRcnUANurUdL
bXdZmmfvLjIM52Mwd+Cn07rTre02nqai/wCHd5ttR2pIWyf2qFMejNQYp2Uhj7RltsDb8IrTCLJV
w1c4UvFW18VUr3leNOrLxIxNPBiHcsC/WT3dnSmnQpmUBpJEtu7H5tqqHZdf0u21rTpsjSJF0/15
1k3OjUECdJF2xA9mnV6q+qeZiywSuSHFaRCVXEHyEBTLVGrVhOYE211GcgYdwSw4nAB929TnCBiD
pfTHLf3iP9V67OlanQ9bXlvB61vEa2XRqy/utKcmPFIJ4NjdaAydRtXBjC2AOJ4ihq1x5EhKTmWz
cVKlcRNSPdmYiTYex6/n7FLwoxpkiJxiC353q+ZUM91rpUKuf3v/AEbayhLVYN6nUxS3xdiOzLOR
Wk+9IEPuFioDAvAnCH+9BFPx9SyReVZS8LWPaI1sMWAkzZasW3YHBWvAgBrY5A6etultvWqnTqzr
5bjVa8NDuYVpuel1tjU6/ZS5gsNWthZz46jImR47hsq42w2MbzbRv5u8eq5Z99raZHWCIzIJAHsg
A4AnHM6sX3K54EHA0lzEYF8yTt9XyrrO6a0Gn1KJBsTUdlf049ilXMdLuZLanhHOQTAsxKx2t+2a
cD7d01leQcEamKj4ZUeYVp1CR7OvS3dAZ2fGQk5zHdxy4qjbQjFjmz7c+oM2zNYihm+WuSRyKkkD
gqSBwSpxwSpxwSphwSpUwVLvlJWsbOvXNK5vWW66xpcvYXtn0WDvLFxUSK6AxMIwWG9ITw+5BQIe
fEVX6fmvHBBxznL+aOSXnNIUY2t1K3MKgnIxY6xHHQXBZy3e2Y92WS2nK76lamZq0xN4kB9hO3/T
5Qr0fg715E7P/KHrSotIwSKinlv7JaxVHlsgqWiksgo+v0rIRoVRfl6Zl+Yro2thUMTiQIjfjh2s
6rlVEVrmLjB3+dbh/wDme7xK1T8Z36KDIVh/sLYa+jkoPxKI2js58ef0F9sIr+peM4PyfbCrfaj9
SJPXl866XntY07dhtLfOvzh56yuGW1Og1KPt/wDy5nWXWvck68xY39afzB6utH3DVP8AFlXBX/HP
ljmPNpcu+KYkC0ahp0pcRUpRj97SepeqW9oLjywQc46pD82RJ+RwsbfwY2t/XPyE16uF4ghblBnU
01pF+k19kpTCqnwVUcYTj/HPR/jnyqN75Yq1W71CcKg4Y6Jf8Z/Iuc8jXZocyjHZMGJ7HHyhbirH
TNrl9n0m6Rt9nQ9Sra5yHP0IBD2JLzqqSvq4oKSIittfR8/qVCHlRL48t+b2dPlNSzlaxlXlMSjW
c6oxGGlnbbLHowOY9hqWdaV3GsKpEAGMNh4+r6d+sX8/f700P9Hwv46fn1P/AI+f2/V/eZ/s6S8t
+IX8wh+GPvSWEofLPdFwquevcPbj2upqDvae3u6mkEatNXO8nlXJBBtGhi/aK97XtCCIKB4+Pj6c
cZhe4W4n4nhx1O76Q773Z34rI95q6dOstkzlm6ECd2BvlxCo6223a/tK3WTBzW6+XZSn2K8w/YKI
244QsqPHooInGTja0YGRjCIMs2Ax6d6DWnIAGRLZYnDoVTaS53DJubPcOvD3F/YGzcK52nXVsDmC
cpVccWRLicuIrqopF5F9Xqq85ZuBbCIp1dGnYJM2G4HcrlLxSTKGp94f1hVlS9ybVrGkbXRQr/ZK
bsS53St2GRt0ac/GmIMKDZw5TT0kXRke64c4VXn4oheS88Zj1LCnVqxkYxNMQMdLAjExIwybuq7C
5lCBAJEjIF33Ajp2qiKbsTsCgsbW3ot62Gltr5FS8tIFnLjSJvKqq/cutOCbvKqq/Wq/HMmpa0ag
EZQiQMgQCB0blajWqRJIkQTnip6Pft712JZwNf3W+ooN057txCr7KVFaluf9t8GnBFxf1ki4VLWl
UIMoRJGTgFuhMK04ggSIfiuy7lt70yFYu7XcO2FcMoK+cc6QTzAznHnZaNOKfkCPuSHTc4X6yM1L
lSXk93pgEaQxbYNmXYwboCrxZu7nt3rmu7HsOq2bN1q99Y63cxxMI9tVSnYcoBcFQNBeYIDRCFVR
eF9UyqtGFWOmcRIbiHCqE5QLxJB4Ksk7Z7UN+1kn2ZtZyL4AbvJBXM5Tmg2CNgMkve5dQQRBRD54
T0+GWPcbdgPDjhl3Rh0YYK77xVx7xxzxKvV1h3Xqmj02pmbW419zp0xLB7XKW3JrXthmRpJS4Miz
jOHy2TZ+AOe2Jo4ADx4EqrmuvOXVK8pewRIM5HfgCGIifU+RO1ZVC6jTA9pxsB7stzq0NX2X2HTx
3YdLvWwUkB6b/MTrq6ylRI33fmjqPoyy4AIaGiEhInKKiZnzs6My8oRJZnIBLbljxr1I4CRHWvAl
WVhZFGKxnyJ5Q47UOGUl03Vajsp4tMt+ar4gCeginoifDLsYRjkGfHrUDInNVdadidgbBWMUl9vO
w3dNFEQjVE+zlyYrYgiIAgy64QCgoKcIienGWIWlGnLVGEQd4ABV2VacgxkSOlTUe+bxrkFazXtz
vaGtKQ3LKvrrGTFYWQ0Qm28rbTgj5gQoqFxyioiphUtqVQ6pwiTliAVUKs4hhIgdK7Q9w22FPrbW
HtFvEtKZlY1PZMzX234jJOOOk2w6JoTYq46ZKgqieREvxVcJUKcgYmIY5hhj0pFSQIIJccV7jfZP
YiSwnpvuxpOD9ialrL95P35SfQ/d8k/fGTnx/bVS/aXnLZtKLNoi3QNzerDoU/Hm76j2lRR903Fi
/c2tnbLlnaHlVXtkCfIGeakniqlKQ/dXlPReSxNvSMNBiNO5g3ZkqFWerU5fe+K9ZrsTsAJbs8N6
2EJ0iMUJ+aNnLR44xuOPGyTnueStk46ZqKrwpES8cquQNpRZtEWd8hnvUvGm76j2qCPt21sUTmrs
7NbM6y8Sm9roTXxgmSr5KRRkP21VV9fUcTQpmevSNW9g/agVJNpctu2LxwyaEkcEpA4JSBwSpxwV
KccEqYcEqVMFS74KlrGzsFza+pwqohF4Cqp5GqKvCfNeE9fTA8EgOVm/072LX/hN2pX7wDNT3G9s
ulIyESqsHIY1z051h14XXjiup7jaxybVtRQk55NAX0Xg7S8n5rtasTSqW/h1jHvgd8RfTIAS9mQI
Or2T9UyGK6GUI8oqxkJRqaoPgTg+w4ZhiGz3snflz+bB/lNrWoa4nXa6Q3qtq9ZlI/mn8w+4VxhW
EDx+1j+Pj5KvPK5uOR+Xf4ZUlPXq1Bsm29JWNzHmvvcRHSzcX+YLBHOlWmW8P8V9dHcPw7rNTOSk
Mdnq9hqlmKHuIz95Kls+54cj5ePlzxynP6c+IfirzA8u89TuwNRpToTZ2fRCEmfY7M69w8rW3vPJ
PCdtYqRfc5IdWy0L8F3+o9w17s0ezTv/APQkpLhykj1AsOy24wETjIOOTfAVMeURS9M6PzB8ch5i
sK3LDZCn7wPD1mqZCBkQ0iBTcgHctbY+Rzy6tG5FbVoLtpZ22PqWc/W26P8AYOn1e1SdasdRfnq4
D1FaiLcpk2jUCQ20JSD1T0Q0EuPXjhUzw/zHyaPKL6drGtCsIt34F4ScPgcj1ONj5rueW3pvKAqm
BgTslmG9Nq1Z/n9/emh/o+F/HT8+r/8AHz+36v7zP9nSXlHxC/mEPwx96SwlHPc1wyy/ldE9eM2W
w9ZRdn2A+3tX1WTsk+c7DYHXH34NYtxKgNEhfcAIxhIW5Jr4OGifQImJZoo8yrGMaxjHwpSEczrx
OkHdnnHMDatkbSm5pgnWA/2cA5G/Lau3Z3S/Wus1/Z8fTb/ZJWx9SPVK3/8AOGoiQprFo4DCjGVj
hwDZcdH1NFQ059B9Oas+YV6kqZqRjpqOzO4044vv+RVXtacBPSS8Wd+K8fUru61/8bN2n0NvNpJ4
9n6qKTYEhyM8gpT358e40Qlx5Ci/H4on6MnXpxqX0BIAjw554/Wgo05mNvIgt34+qSvBP1ep7R1z
SN47fsbSDtTPXl7smyW8Fpora4gVNmxEqJUoX/FHHJDbjrKPH9Ri2BkpInJYMa0rac6dAAx8SMQD
7MTKJMgG3YFtjkLJNMVoxnUJfSSd5ALDt3qga/pzTry76jGonXcah7Oo9nu/GWcc5ccKWZbsRg82
2hb5NuubVz6V4Ui49OMyZ39WEauoDVAxG1jqESdv2iytRtoSlBnaQJ7CfoVU0HSXVjt/Qdd32z7K
PYNnqgbTKlwI0YqdCk05XbEACPye5SMoeT6IQefIeKJ9Y2avMbgQlVjGOgS04k6sJaCd2ezd2K5C
1pahAk6iH4Zam7Nqt1v3X2rUGlaZtem2djs8Ozajs7NsCrEWvYs5EUZBQUaaP7qM60YvB4yQT3RD
3W1UF9Mu1uqlSrOFQCJGQxdnZ9xBwyydirNajGMIyiSXzODPu3jrzzVoAzOWMlhglLDIlSSwyJSl
hglLDIlKWGCklBkUpYZFKUGCUoMilJHBKSORUkkcEpA4JSBwVKccEqccEqYcEqUcFS74JWsbOwXN
LmUqX0BFSEVJGxJUQnFReBRfiqoKKvp+pMJEs+fpxSA5Vx+zeuHutLWpqn9jqdkctaqNZ+/UOm62
yrw8OMuEQAiG24Jgo/tJx9Qiq8ZzXlfzLHntCpVjRqUhCpKDVAAZNlIMTgYmJfLHumQxWy5ny02M
4xM4yeIPdfDeDhsLj6FbhBJUJUFVQE5NUTlERV4RV/R6rxnSkgda1oBK3vfhjKSD+L2mTSYckjDC
3fKOyoI4aNz5JKIe4QByqJ6eRIn6VTPhX40U/F84XMHAfwg5dg9OGbAnsBPBe6+TZ6OUQkzsZ/eO
9X56x30eytQg7YOu2erpLdeZWpt2xZkgTDigqq2hKSIvHKeSCq/HjjhV4HzLyL+C3srQ1YVdIB1U
zqidQfNmPFnHF3A3/LL/AN+oCrolB3wlgcPTarg/FeV9VX4rmhWwWnf8/f700P8AR8L+On59l/4+
f2/V/eZ/s6S8a+IX8wh+GPvSWEgZ7ouFV55PfHbM7UV0iVuDrtCde3UPn9rEGwdrWuPbgu2YsJNc
jCgoiMm8rfiiD4+KcZrxyy3jU8QR7zvmWffpfS/FnWV73VMND4M2x23Pm3B14tl2Vu127ub9pdfc
u9hfa/6wP7aMH3n2ToPMegND7fgbYr+78eePXlMuQtKUBBh7D6cTg+foVGVectTn2s17ei9v7913
V2tLqtlBjVd1KjzrCFPqKy0BZUUHW2H2/wCYxZKtGAvGiE2or9S5bubCjcSEpguA2BlHA5jukPlt
U6VzOkCInA8AfWFFK7O32zuNnv7PZpVndbnWnUbJYzPCQ7JguE0SscuiXtinsgg+34+KDwPCemMb
OjGMYxiAIlwBgx3/AC7VRr1CTIlyQx6F7tD3J2TrmpSNIptk+z1yQzMjpH+0huSGGbAfGY1GmuMF
Jjg+iqjgtOCh8r5IvOWqthQqVPElHvYbS2GTh2LbHCnC5qRjoBw6tueOayT03ufUNY1yitWd+sXJ
lLp8mkf0CZRRHrR+e5BeiAw1sYtI8NYrrgvIyTv7sU9tGy9CzUXHL6lWZjoDGYOoSLM4L6MtbYO2
ObrOpXUIRB1HCLMwd2b2vydrLHG+7P3jatcqNSu7oZOvUhtOw69mJEi+brDKx2XZLkdltyS420qg
JvEZCKqiKiKubalZ0qUzOI7x2uTxwc4Y7mWFOvOcREnAenX1qiwzIVpLDApSwyKklh8silLDBKWG
RSlhkSpJQYJSwyJSlBglKHIqQSQwVJIYKSSORSkDglIHBUpxwSpxwSphwSpRwVLvglaxs7Bc0uZS
pcylS4iceiemUlXI1DsmZqGq7xqrFDU2jO8RmosiznxWnpUJGS9xCimYF4qpoCr5cp9KeKCX1JzP
OPLNPmV7bXcqtSBt5EiMZGMZvg0wCMNOoYMe9iTHurZWfM5W1GpSEYkTDOQCR0dbdm/FbD/xm/Kz
qLrDpfUtJ2qZaNXtUs0prUeCTzSJImPPBwaFwv0GnP68+f8A4mfCjnnPuf1760jA0p6GeYie7CMT
g28FeheWvNljYWMKNUy1AyyD5klX8/8A3X0ES8/zG7VV+K/y1z/azgv+iPM35FL9YPoW+/rzlm+X
6K7J+dHQa/8AuN1/u1z/AGsf+iPM35FL9YPoVf13yzfL9Fa9Pyu7U1Ht7sip2fTHpT9XE16NWvlL
YWOaPtSpbpIgqqqqeLo+ufRXwk8qX3lvlNS1vRETlWlMaTqGkwhEY73iV515t5tQ5ldxq0CdIgBi
GxBkfnWNY56guYSQ+WRSEoMEpQZFKUGCUoMilLDBKWGRKklhkUpYYJSg+WRUksMiUpYYJSwyKklh
kUpQYJSwyKUoMEpQZFKSGCkkjglJHIpSBwVJA4KSnHBUpxwSphwSpRwVKTKStYudceK5pcTKVLun
H6spKkTw/wC7/llKlKntfPw/ywSlB8E4+HywSkDkUqccEpI4KkgPlglKD5ZFSSQwSlBkUpQYFKUG
RSlhglLDIlSSwyJSlBglLDIpSwyKklh8sClLDIpSwwUkoMiUpYZFKUGCUoMilJHBSSRyKUkMFSQO
CkkDgqU4/wCeCVOOCVMOCVKmCVJgqX//2Q==

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://eldd.emcdda.europa.eu/public/images/arrow_on.gif

R0lGODlhCwALAJECAP///2aFowAAAAAAACH5BAEAAAIALAAAAAALAAsAAAITlI+pEu0PYwRAOgqp
xpLPaoVWAQA7

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://eldd.emcdda.europa.eu/plugins/eldd/images/languages/de.jpg
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------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://eldd.emcdda.europa.eu/plugins/eldd/images/languages/en2.jpg
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=

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://eldd.emcdda.europa.eu/public/images/button.gif

R0lGODlhDgAPAJEAAP///3qVrwAzZgAAACH5BAAAAAAALAAAAAAOAA8AAAIjjI8py73mooCy0fpC
AyDexTkf2DFjaGkMmmKm6o6S7CX2UQAAOw==

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://eldd.emcdda.europa.eu/editor.css

.font_Style1 {
	FONT-WEIGHT: normal; FONT-SIZE: 11px; COLOR: #000000
}
.font_Style2 {
	FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #000000
}
.font_footNotes {
	FONT-SIZE: 9px
}
.font_footNotes UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; LIST-STYLE-POSITION: outside; =
BACKGROUND: url(/public/css/hr.gif) no-repeat left top; PADDING-BOTTOM: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
.font_footNotes LI {
	DISPLAY: block; MARGIN-BOTTOM: 5px; LINE-HEIGHT: 2.5ex; PADDING-TOP: =
5px; TEXT-ALIGN: left
}
.font_footNotes LI A:link {
	FONT-SIZE: 11px
}
.font_footNotes LI A:visited {
	FONT-SIZE: 11px
}
.font_reitoxButton {
	PADDING-RIGHT: 1.6em; PADDING-LEFT: 1em; BACKGROUND: rgb(168,185,203); =
PADDING-BOTTOM: 1.1em; MARGIN: 0px; PADDING-TOP: 0.1em; LIST-STYLE-TYPE: =
none
}
.font_reitoxButton LI {
	BORDER-RIGHT: windowtext 1pt solid; PADDING-RIGHT: 0.3em; BORDER-TOP: =
windowtext 1pt solid; PADDING-LEFT: 0.3em; FONT-WEIGHT: bold; FONT-SIZE: =
10pt; PADDING-BOTTOM: 0.3em; MARGIN: 1em 0px 0px; BORDER-LEFT: =
windowtext 1pt solid; WIDTH: 100%; COLOR: navy; PADDING-TOP: 0.3em; =
BORDER-BOTTOM: windowtext 1pt solid; FONT-FAMILY: 'courier new'; =
BACKGROUND-COLOR: rgb(243,243,243); TEXT-ALIGN: center
}
.table_Table1 {
	BORDER-RIGHT: #dadada 1px solid; BORDER-TOP: #dadada 1px solid; MARGIN: =
0px 0px 10px; BORDER-LEFT: #dadada 1px solid; WIDTH: 620px; =
BORDER-BOTTOM: #dadada 1px solid
}
.table_Table1 TD {
	PADDING-RIGHT: 5px; PADDING-LEFT: 5px; FONT-SIZE: 8pt; PADDING-BOTTOM: =
2px; VERTICAL-ALIGN: top; COLOR: #000000; PADDING-TOP: 2px; FONT-FAMILY: =
Arial, Helvetica, sans-serif
}
.table_Table2 {
	BORDER-RIGHT: #ff0000 1px solid; BORDER-TOP: #ff0000 1px solid; =
BORDER-LEFT: #ff0000 1px solid; BORDER-BOTTOM: #ff0000 1px solid; =
BORDER-COLLAPSE: collapse
}
.table_Table2 TD {
	BORDER-RIGHT: #ff0000 1px solid; BORDER-TOP: #ff0000 1px solid; =
BORDER-LEFT: #ff0000 1px solid; BORDER-BOTTOM: #ff0000 1px solid; =
BORDER-COLLAPSE: collapse
}
.table_Table3 {
	BORDER-RIGHT: #ffffff 0px solid; BORDER-TOP: #ffffff 0px solid; =
BORDER-LEFT: #ffffff 0px solid; BORDER-BOTTOM: #ffffff 0px solid; =
BORDER-COLLAPSE: collapse; BACKGROUND-COLOR: #cccccc
}
.table_Table3 TD {
	BORDER-RIGHT: #ffffff 0px solid; BORDER-TOP: #ffffff 0px solid; =
BORDER-LEFT: #ffffff 0px solid; BORDER-BOTTOM: #ffffff 0px solid; =
BORDER-COLLAPSE: collapse; BACKGROUND-COLOR: #cccccc
}
.table_Table4 {
	BORDER-RIGHT: #ffffff 0px solid; BORDER-TOP: #ffffff 0px solid; =
BORDER-LEFT: #ffffff 0px solid; BORDER-BOTTOM: #ffffff 0px solid
}
.table_Table4 TD {
	BORDER-RIGHT: #ffffff 0px solid; BORDER-TOP: #ffffff 0px solid; =
BORDER-LEFT: #ffffff 0px solid; BORDER-BOTTOM: #ffffff 0px solid
}
.tablerow_TitleRow {
	PADDING-RIGHT: 3px; PADDING-LEFT: 3px; FONT-WEIGHT: bold; FONT-SIZE: =
9px; PADDING-BOTTOM: 3px; PADDING-TOP: 3px; BACKGROUND-COLOR: #a8b9cb
}
.tablerow_Row1 {
	BACKGROUND-COLOR: #cccccc
}
.tablerow_Row2 {
	BACKGROUND-COLOR: #e5eaef
}

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://eldd.emcdda.europa.eu/specific.css

BODY#page190 A IMG {
	BORDER-RIGHT: #627bb1 1px solid; BORDER-TOP: #627bb1 1px solid; =
BORDER-LEFT: #627bb1 1px solid; BORDER-BOTTOM: #627bb1 1px solid
}
BODY#page190 A:visited IMG {
	BORDER-RIGHT: #627bb1 1px solid; BORDER-TOP: #627bb1 1px solid; =
BORDER-LEFT: #627bb1 1px solid; BORDER-BOTTOM: #627bb1 1px solid
}
BODY#page190 #headersection A IMG {
	BORDER-TOP-STYLE: none; BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: =
none; BORDER-BOTTOM-STYLE: none
}
BODY#page190 #headersection A:visited IMG {
	BORDER-TOP-STYLE: none; BORDER-RIGHT-STYLE: none; BORDER-LEFT-STYLE: =
none; BORDER-BOTTOM-STYLE: none
}
BODY#page132 .groupboxlc {
	MARGIN-LEFT: 128px
}
* HTML BODY#page132 .groupboxlc {
	MARGIN-LEFT: 0px
}
.countryprofileseven {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 3px; WIDTH: =
800px; PADDING-TOP: 0px
}
.countryprofilesodd {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 3px; WIDTH: =
800px; PADDING-TOP: 0px
}
.countryprofileseven {
	BACKGROUND-COLOR: #ffffff
}
.countryprofilesodd {
	BACKGROUND-COLOR: #f6f5f5
}
TABLE.csstab1 {
	BORDER-RIGHT: #889db2 1px solid; BORDER-TOP: #889db2 1px solid; MARGIN: =
1em 0px 0px; BORDER-LEFT: #889db2 1px solid; WIDTH: 780px; =
BORDER-BOTTOM: #889db2 1px solid; BORDER-COLLAPSE: collapse
}
TABLE.csstab2 {
	BORDER-RIGHT: #889db2 1px solid; BORDER-TOP: #889db2 1px solid; MARGIN: =
1em 0px 0px; BORDER-LEFT: #889db2 1px solid; WIDTH: 780px; =
BORDER-BOTTOM: #889db2 1px solid; BORDER-COLLAPSE: collapse
}
TABLE.csstab1 P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 90%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px
}
TABLE.csstab2 P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 90%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px
}
TABLE.csstab1 TD {
	PADDING-RIGHT: 0.5em; BORDER-TOP: #ccd3e0 1px solid; PADDING-LEFT: =
0.5em; PADDING-BOTTOM: 0.5em; VERTICAL-ALIGN: top; BORDER-LEFT: #ccd3e0 =
1px solid; PADDING-TOP: 0.5em; BACKGROUND-COLOR: #f6f7f6; TEXT-ALIGN: =
left
}
TABLE.csstab2 TD {
	PADDING-RIGHT: 0.5em; BORDER-TOP: #ccd3e0 1px solid; PADDING-LEFT: =
0.5em; PADDING-BOTTOM: 0.5em; VERTICAL-ALIGN: top; BORDER-LEFT: #ccd3e0 =
1px solid; PADDING-TOP: 0.5em; BACKGROUND-COLOR: #f6f7f6; TEXT-ALIGN: =
left
}
TABLE.csstab1 TD.td11 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab1 TD.td12 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab1 TD.td13 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab1 TD.td14 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab1 TD.td15 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab2 TD.td21 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab2 TD.td22 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab2 TD.td23 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab2 TD.td24 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
TABLE.csstab2 TD.td25 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #335c85
}
BODY#page18073 .groupboxwhite {
	FLOAT: left; WIDTH: 300px
}
.groupboxblue {
	CLEAR: none; BORDER-RIGHT: #b4bada 1px solid; BORDER-TOP: #b4bada 1px =
solid; MARGIN-TOP: 15px; FLOAT: left; BORDER-LEFT: #b4bada 1px solid; =
WIDTH: 300px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: #b4bada 1px solid; =
BACKGROUND-COLOR: #eceef6
}
.groupboxblue .groupboxitem .groupboxitemtitle A {
	COLOR: #003082; BACKGROUND-COLOR: #eceef6
}

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://eldd.emcdda.europa.eu/public/cssSettings/default.css

@import url( editor.css );
@import url( specific.css );
.highlight {
	BACKGROUND-COLOR: #e5eaf2
}
TABLE {
	CLEAR: both
}
BODY {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: small; =
PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; =
FONT-FAMILY: Arial, Helvetica, sans-serif; POSITION: relative; HEIGHT: =
100%
}
IMG {
	VERTICAL-ALIGN: bottom
}
A IMG {
	BORDER-RIGHT: #ffffff 1px solid; BORDER-TOP: #ffffff 1px solid; =
BORDER-LEFT: #ffffff 1px solid; BORDER-BOTTOM: #ffffff 1px solid
}
A:visited IMG {
	BORDER-RIGHT: #ffffff 1px solid; BORDER-TOP: #ffffff 1px solid; =
BORDER-LEFT: #ffffff 1px solid; BORDER-BOTTOM: #ffffff 1px solid
}
A:hover IMG {
	BORDER-RIGHT: #003082 1px solid; BORDER-TOP: #003082 1px solid; =
BORDER-LEFT: #003082 1px solid; BORDER-BOTTOM: #003082 1px solid
}
#previewzone {
	opacity: 1
}
#content-wrapper {
	FLOAT: right; MARGIN: 0% 1% 0% 0%; WIDTH: 84%
}
#content {
	MARGIN-TOP: 8px; PADDING-LEFT: 16px
}
#footersection {
	BORDER-TOP: #264f95 1px solid; FONT-SIZE: 80%; FLOAT: left; MARGIN: =
12px 0px; WIDTH: 100%; COLOR: #000; BACKGROUND-COLOR: #fff
}
#footersection A {
	FONT-SIZE: 80%; COLOR: #000; BACKGROUND-COLOR: #fff
}
#footersection A:visited {
	FONT-SIZE: 80%; COLOR: #000; BACKGROUND-COLOR: #fff
}
#footersection A:hover {
	COLOR: #000; BACKGROUND-COLOR: #fff; TEXT-DECORATION: none
}
#footerlinks {
	FLOAT: left
}
#lastupdate {
	FLOAT: left; MARGIN: 4px 0px 0px 25%; WIDTH: 20em; TEXT-DECORATION: =
none
}
#lastupdate A {
	FONT-STYLE: italic; TEXT-DECORATION: none
}
#footerprint {
	FLOAT: right
}
TD {
	VERTICAL-ALIGN: top
}
#headersection {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; BACKGROUND: =
url(/public/images/sites/blue_gradient.jpg) #627bb1 no-repeat left top; =
FLOAT: left; PADDING-BOTTOM: 12px; MARGIN: 0px; WIDTH: 100%; COLOR: =
#ffffff; PADDING-TOP: 12px
}
#logosection {
	FLOAT: left; WIDTH: 20%
}
#logosection A IMG {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; MARGIN: 0px; BORDER-RIGHT-WIDTH: 0px
}
#headertools {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: right; MAX-WIDTH: 500px; =
PADDING-BOTTOM: 0px; MARGIN: 0px 6px 0px 0px; WIDTH: auto; PADDING-TOP: =
0px
}
#languagelist {
	FONT-SIZE: 80%; MARGIN: 6px 0px 0px; LIST-STYLE-TYPE: none; TEXT-ALIGN: =
left
}
#languagelist LI {
	BORDER-RIGHT: #264d93 1px solid; BORDER-TOP: #264d93 1px solid; =
FONT-SIZE: 100%; FLOAT: right; MARGIN: 0px 0px 0.5em 0.4em; BORDER-LEFT: =
#264d93 1px solid; BORDER-BOTTOM: #264d93 1px solid
}
#languagelist LI.on {
	PADDING-RIGHT: 0.2em; DISPLAY: block; PADDING-LEFT: 0.2em; FLOAT: =
right; PADDING-BOTTOM: 0.2em; COLOR: #003082; PADDING-TOP: 0.2em; =
BACKGROUND-COLOR: #fdd44f
}
#languagelist LI.off A {
	PADDING-RIGHT: 0.2em; DISPLAY: block; PADDING-LEFT: 0.2em; FLOAT: left; =
PADDING-BOTTOM: 0.2em; COLOR: #f6f7f6; PADDING-TOP: 0.2em; =
BACKGROUND-COLOR: #496dab; TEXT-DECORATION: none
}
#languagelist LI.off A:hover {
	COLOR: #ffffff; BACKGROUND-COLOR: #003082; TEXT-DECORATION: none
}
#languagelist LI.off A:focus {
	COLOR: #ffffff; BACKGROUND-COLOR: #003082; TEXT-DECORATION: none
}
#advsearch {
	CLEAR: right; FONT-SIZE: 85%; FLOAT: right; MARGIN: 0px; WIDTH: 180px; =
PADDING-TOP: 0.2em; TEXT-ALIGN: right
}
#searchtext {
	CLEAR: right; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: right; =
PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 180px; PADDING-TOP: 0px; =
TEXT-ALIGN: right
}
#advsearch A {
	FLOAT: right; MARGIN-BOTTOM: 0px; WIDTH: auto; COLOR: #f6f7f6; =
BACKGROUND-COLOR: #627bb1; TEXT-DECORATION: none
}
#advsearch A:hover {
	TEXT-DECORATION: underline
}
#navbar {
	PADDING-RIGHT: 0px; BORDER-TOP: #fedf7b 1px solid; PADDING-LEFT: 0px; =
FLOAT: left; PADDING-BOTTOM: 0px; MARGIN: 0px; WIDTH: 100%; COLOR: =
#fedf7b; PADDING-TOP: 0px; BORDER-BOTTOM: #fedf7b 1px solid; =
LIST-STYLE-TYPE: none; BACKGROUND-COLOR: #003082
}
#navbar LI {
	BORDER-RIGHT: #b4bada 1px solid; FONT-WEIGHT: bold; FONT-SIZE: 90%; =
FLOAT: left; MARGIN: 2px 0px; COLOR: #fedf7b; BACKGROUND-COLOR: #003082
}
#navbar A {
	PADDING-RIGHT: 6px; DISPLAY: block; PADDING-LEFT: 6px; FLOAT: left; =
PADDING-BOTTOM: 1px; COLOR: #fdd44f; PADDING-TOP: 1px; BACKGROUND-COLOR: =
#003082; TEXT-DECORATION: none
}
#navbar LI.current {
	PADDING-RIGHT: 6px; DISPLAY: block; PADDING-LEFT: 6px; FLOAT: left; =
PADDING-BOTTOM: 1px; COLOR: #fdd44f; PADDING-TOP: 1px; BACKGROUND-COLOR: =
#003082; TEXT-DECORATION: none
}
#navbar A:hover {
	COLOR: #003082; BACKGROUND-COLOR: #fdd44f
}
#breadcrumbsanduserid {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; FONT-SIZE: 80%; FLOAT: left; =
PADDING-BOTTOM: 3px; MARGIN: 0px; WIDTH: 99%; COLOR: #f4f5fa; =
PADDING-TOP: 2px; BORDER-BOTTOM: #264f95 1px solid; BACKGROUND-COLOR: =
#496da6
}
#breadcrumbs {
	FONT-SIZE: 100%; FLOAT: left; WIDTH: 80%
}
#breadcrumbscurrent {
	FONT-WEIGHT: bold; COLOR: #fff; BACKGROUND-COLOR: #496da6
}
#breadcrumbstrail A {
	VERTICAL-ALIGN: bottom; COLOR: #cdd1e7; BACKGROUND-COLOR: #496da6; =
TEXT-DECORATION: none
}
#breadcrumbstrail A:hover {
	COLOR: #fff; BACKGROUND-COLOR: #496da6
}
#currentuser {
	FONT-SIZE: 100%; FLOAT: right; WIDTH: 20%; TEXT-ALIGN: right
}
#childnavigation {
	BORDER-RIGHT: #eceef6 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: =
#eceef6 1px solid; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: 3px; =
MARGIN: 0px 0px 9px; BORDER-LEFT: #eceef6 1px solid; WIDTH: 100%; COLOR: =
#003082; PADDING-TOP: 0px; BORDER-BOTTOM: #eceef6 1px solid; =
BACKGROUND-COLOR: #f4f5fa
}
#childnavigation UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
3px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#childnavigation LI {
	PADDING-RIGHT: 20px; PADDING-LEFT: 0px; FONT-SIZE: 85%; FLOAT: left; =
PADDING-BOTTOM: 0px; WIDTH: 20em; PADDING-TOP: 3px
}
#childnavigation LI A {
	COLOR: #003082; BACKGROUND-COLOR: #f4f5fa; TEXT-DECORATION: none
}
#childnavigation LI A:hover {
	TEXT-DECORATION: underline
}
#childnavigation LI A:visited {
	COLOR: #3b6ea1; BACKGROUND-COLOR: #f4f5fa
}
#leftsidebar {
	BORDER-RIGHT: #b4bada 1px solid; MIN-HEIGHT: 650px; FLOAT: left; =
OVERFLOW: hidden; WIDTH: 14%; COLOR: #003082; BORDER-BOTTOM: #b4bada 1px =
solid; HEIGHT: auto; BACKGROUND-COLOR: #eceef6
}
* HTML BODY #leftsidebar {
	PADDING-BOTTOM: 480px
}
#siblingnavigation {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; WIDTH: auto; COLOR: #003082; PADDING-TOP: 0px; BACKGROUND-COLOR: =
#f4f5fa
}
#siblingnavigation UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#siblingnavigation LI {
	PADDING-RIGHT: 0px; BORDER-TOP: #ffffff 1px solid; PADDING-LEFT: 6px; =
FONT-SIZE: 85%; PADDING-BOTTOM: 3px; PADDING-TOP: 3px
}
#siblingnavigation LI A {
	COLOR: #003082; BACKGROUND-COLOR: #f4f5fa; TEXT-DECORATION: none
}
#siblingnavigation LI A:hover {
	TEXT-DECORATION: underline
}
#siblingnavigation LI#current {
	COLOR: #333333; BACKGROUND-COLOR: #ffffff
}
#furtheroptions {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FLOAT: left; PADDING-BOTTOM: =
0px; MARGIN: 0px; WIDTH: 100%; PADDING-TOP: 0px; BORDER-BOTTOM: #879cb3 =
1px solid
}
#furtheroptionstitle {
	PADDING-RIGHT: 0px; BORDER-TOP: #848fc0 1px solid; DISPLAY: block; =
PADDING-LEFT: 6px; FONT-WEIGHT: bold; FONT-SIZE: 85%; PADDING-BOTTOM: =
3px; MARGIN: 0px; COLOR: #ffffff; PADDING-TOP: 3px; BORDER-BOTTOM: =
#848fc0 1px solid; BACKGROUND-COLOR: #879bc3
}
#furtheroptions UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
#furtheroptions LI {
	PADDING-RIGHT: 0px; BORDER-TOP: #f4f5fa 1px solid; MARGIN-TOP: 0px; =
DISPLAY: block; PADDING-LEFT: 3px; FONT-SIZE: 80%; PADDING-BOTTOM: 3px; =
TEXT-INDENT: 4px; PADDING-TOP: 3px
}
#furtheroptions LI A {
	COLOR: #003082; BACKGROUND-COLOR: #eceef6; TEXT-DECORATION: none
}
#furtheroptions LI A:hover {
	TEXT-DECORATION: underline
}
#printpage {
	BORDER-TOP: #eceef6 1px solid; COLOR: #fff; BACKGROUND-COLOR: #b4bada
}
LI#printpage A {
	PADDING-BOTTOM: 0px; COLOR: #fff; BACKGROUND-COLOR: #b4bada
}
BODY {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY DIV {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY P {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY TH {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY TD {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY LI {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
BODY DD {
	FONT-SIZE: small; FONT-FAMILY: arial, helvetica, sans-serif; =
voice-family: inherit
}
HTML > BODY {
	FONT-SIZE: small
}
HTML > BODY DIV {
	FONT-SIZE: small
}
HTML > BODY P {
	FONT-SIZE: small
}
HTML > BODY TH {
	FONT-SIZE: small
}
HTML > BODY TD {
	FONT-SIZE: small
}
HTML > BODY LI {
	FONT-SIZE: small
}
HTML > BODY DD {
	FONT-SIZE: small
}
TEXTAREA {
	FONT-SIZE: 100%; FONT-FAMILY: Arial, Helvetica, sans-serif
}
TD {
	FONT-SIZE: 100%; FONT-FAMILY: Arial, Helvetica, sans-serif
}
P {
	FONT-SIZE: 100%; FONT-FAMILY: Arial, Helvetica, sans-serif
}
A {
	COLOR: #003082; TEXT-DECORATION: underline
}
A:visited {
	COLOR: #003082
}
A:hover {
	TEXT-DECORATION: none
}
.pageCopy {
	FONT-SIZE: small; FONT-FAMILY: Arial, Helvetica, sans-serif
}
.searchResultItem {
	MARGIN-BOTTOM: 14px
}
.pageStep {
	FLOAT: right
}
H1 {
	MARGIN-TOP: 5px; FONT-SIZE: 125%; MARGIN-BOTTOM: 0px; PADDING-BOTTOM: =
3px; WIDTH: 100%; COLOR: #003082; FONT-FAMILY: Arial, Helvetica, =
sans-serif
}
H2 {
	MARGIN-TOP: 10px; FONT-WEIGHT: bold; FONT-SIZE: 95%; MARGIN-BOTTOM: =
5px; COLOR: #000000
}
H3 {
	MARGIN-TOP: 20px; FONT-SIZE: 105%; MARGIN-BOTTOM: 5px; COLOR: #003082
}
.groupboxrss .groupboxheader {
	DISPLAY: none
}
.groupboxrss .groupboxitemtitle {
	DISPLAY: none
}
.groupboxrss .groupboxitemdate {
	DISPLAY: none
}
.groupboxrss .groupboxblue .groupboxheader {
	DISPLAY: block
}
.groupboxrss .groupboxblue .groupboxitemtitle {
	DISPLAY: block
}
.groupboxblue .groupboxitemdate {
	DISPLAY: block
}
.groupboxrss .groupboxitem {
	CLEAR: none; PADDING-RIGHT: 0px; BORDER-TOP: #ccd6e0 0px solid; =
PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; COLOR: black; PADDING-TOP: 0px
}
.groupboxrss .groupboxitemcontent {
	CLEAR: none; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 100%; =
PADDING-BOTTOM: 0px; MARGIN: 0px; PADDING-TOP: 0px
}
.groupboxes {
	CLEAR: left; PADDING-BOTTOM: 25px; WIDTH: 100%
}
.groupboxbluewide {
	BORDER-RIGHT: #ccd6e0 1px solid; BORDER-TOP: #ccd6e0 1px solid; =
MARGIN-TOP: 10px; MARGIN-BOTTOM: 10px; BORDER-LEFT: #ccd6e0 1px solid; =
WIDTH: 100%; BORDER-BOTTOM: #ccd6e0 1px solid; BACKGROUND-COLOR: #e4e8f4
}
.bluebox-small {
	MARGIN-TOP: 10px; WIDTH: 50%; BACKGROUND-COLOR: #e4e8f4
}
.bluebox-small TD {
	FONT-SIZE: 80%
}
.bluebox .img {
	PADDING-RIGHT: 25px; PADDING-LEFT: 25px; PADDING-BOTTOM: 25px; =
PADDING-TOP: 25px
}
.groupboxwhite {
	CLEAR: none; MARGIN-TOP: 15px; FLOAT: left; WIDTH: 95%; MARGIN-RIGHT: =
10px; BACKGROUND-COLOR: #ffffff
}
.groupboxwhiteitemtitle {
	FONT-WEIGHT: bold; FONT-SIZE: 105%; WIDTH: 100%; COLOR: #003082; =
PADDING-TOP: 2px
}
.groupboxblue {
	CLEAR: none; BORDER-RIGHT: #b4bada 1px solid; BORDER-TOP: #b4bada 1px =
solid; MARGIN-TOP: 15px; FLOAT: left; BORDER-LEFT: #b4bada 1px solid; =
WIDTH: 300px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: #b4bada 1px solid; =
BACKGROUND-COLOR: #eceef6
}
.groupboxblue .groupboxitem .groupboxitemtitle A {
	COLOR: #003082; BACKGROUND-COLOR: #eceef6
}
.groupboxheader {
	PADDING-LEFT: 6px; FONT-WEIGHT: bold; FONT-SIZE: 90%; PADDING-BOTTOM: =
2px; COLOR: white; PADDING-TOP: 2px; BACKGROUND-COLOR: #35609f; =
BORDER-BOTTOM-STYLE: none
}
.groupboxheader A {
	COLOR: #ffffff
}
.groupboxheader A:visited {
	COLOR: #ffffff
}
.groupboxheader A:hover {
	COLOR: #ffffff
}
.groupboxheaderright {
	PADDING-LEFT: 4px; FONT-WEIGHT: bold; FONT-SIZE: 90%; PADDING-BOTTOM: =
2px; COLOR: white; PADDING-TOP: 2px; BORDER-BOTTOM: #889db2 1px solid; =
BACKGROUND-COLOR: #9babc2; TEXT-ALIGN: right
}
.groupboxitemtitle {
	FONT-WEIGHT: bold; FONT-SIZE: 100%
}
.groupboxitemtitle A {
	TEXT-DECORATION: none
}
.groupboxitemtitle A:hover:link {
	TEXT-DECORATION: underline
}
.groupboxitem {
	CLEAR: left; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; PADDING-BOTTOM: =
4px; COLOR: #000000; PADDING-TOP: 4px
}
.groupboxrss .groupboxblue .groupboxitem {
	CLEAR: left; PADDING-RIGHT: 4px; PADDING-LEFT: 4px; PADDING-BOTTOM: =
4px; COLOR: #000000; PADDING-TOP: 4px
}
[previewed=3D'true'].groupboxitem {
	BORDER-RIGHT: #cc0000 4px solid; BORDER-TOP: #cc0000 4px solid; =
BORDER-LEFT: #cc0000 4px solid; BORDER-BOTTOM: #cc0000 4px solid; =
POSITION: relative; opacity: 1
}
.groupboxitem {
	BORDER-TOP: #b4bada 1px solid
}
.groupboxrss .groupboxblue .groupboxitem {
	BORDER-TOP: #b4bada 1px solid
}
.groupboxitemdate {
	CLEAR: left; DISPLAY: none; FONT-SIZE: 90%; WIDTH: 100%
}
.groupboxitemcontent {
	CLEAR: left; FONT-SIZE: 95%; MARGIN-BOTTOM: 0px
}
.groupboxrss .groupboxblue .groupboxitemcontent {
	CLEAR: left; FONT-SIZE: 95%; MARGIN-BOTTOM: 0px
}
.groupboxspacer {
	MARGIN-BOTTOM: 15px
}
.groupboxtbl {
	BORDER-RIGHT: #889db2 1px solid; BORDER-TOP: #889db2 1px solid; =
MARGIN-TOP: 10px; BORDER-LEFT: #889db2 1px solid; WIDTH: 100%; =
BORDER-BOTTOM: #889db2 1px solid
}
.groupboxtbl TD {
	PADDING-RIGHT: 4px; PADDING-LEFT: 4px; PADDING-BOTTOM: 4px; =
PADDING-TOP: 4px
}
.groupboxtbl .groupboxheader {
	BACKGROUND-COLOR: #335c85
}
.attachment {
	CLEAR: left; FLOAT: left; MARGIN-BOTTOM: 5px; WIDTH: 99%
}
.attachmentitem {
	CLEAR: left; FLOAT: left
}
.attachmenttext {
	FONT-SIZE: 70%; MARGIN-BOTTOM: 0px
}
.attachmenttitle {
	MARGIN-TOP: 10px; FONT-WEIGHT: bold; FONT-SIZE: 70%; COLOR: #333333; =
FONT-FAMILY: Arial, Helvetica, sans-serif
}
.attachmentlngbox {
	BORDER-RIGHT: #6d7cb3 1px solid; PADDING-RIGHT: 0px; BORDER-TOP: =
#6d7cb3 1px solid; PADDING-LEFT: 0px; FONT-SIZE: 70%; FLOAT: left; =
PADDING-BOTTOM: 5px; MARGIN: 1px; BORDER-LEFT: #6d7cb3 1px solid; WIDTH: =
15px; COLOR: #6d7cb3; PADDING-TOP: 5px; BORDER-BOTTOM: #6d7cb3 1px =
solid; BACKGROUND-COLOR: #fff; TEXT-ALIGN: center
}
.attachmentlngbox A {
	COLOR: #003082; FONT-STYLE: normal; TEXT-DECORATION: none
}
.attachmentlngBox A:hover {
	COLOR: #003082; FONT-STYLE: normal; TEXT-DECORATION: none
}
.attachmentlngbox A:active {
	COLOR: #003082; FONT-STYLE: normal; TEXT-DECORATION: none
}
.attachmentlngbox A:visited {
	COLOR: #003082; FONT-STYLE: normal; TEXT-DECORATION: none
}
.attachmenticon {
	CLEAR: left; FLOAT: left; MARGIN-RIGHT: 3px
}
.img {
	BORDER-TOP-WIDTH: 1px; PADDING-RIGHT: 0px; PADDING-LEFT: 0px; =
BORDER-LEFT-WIDTH: 1px; BORDER-BOTTOM-WIDTH: 1px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px; BORDER-RIGHT-WIDTH: 1px
}
.tree {
	CLEAR: none; FLOAT: left; PADDING-BOTTOM: 30px; MARGIN-LEFT: 2px
}
.tree A {
	FONT-WEIGHT: normal; FONT-SIZE: 90%; COLOR: #000
}
.tree A:hover {
	FONT-WEIGHT: normal; COLOR: #000; BACKGROUND-COLOR: #d0e0f5
}
.pagecopy IMG {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; BORDER-LEFT-COLOR: #ccd6e0; =
BORDER-BOTTOM-COLOR: #ccd6e0; PADDING-BOTTOM: 2px; MARGIN: 2px; =
BORDER-TOP-COLOR: #ccd6e0; PADDING-TOP: 2px; BORDER-RIGHT-COLOR: #ccd6e0
}
.pagecopy P TD {
	PADDING-RIGHT: 2px; PADDING-LEFT: 2px; BORDER-LEFT-COLOR: #ccd6e0; =
BORDER-BOTTOM-COLOR: #ccd6e0; PADDING-BOTTOM: 2px; MARGIN: 2px; =
VERTICAL-ALIGN: top; BORDER-TOP-COLOR: #ccd6e0; PADDING-TOP: 2px; =
TEXT-ALIGN: left; BORDER-RIGHT-COLOR: #ccd6e0
}
.fn {
	FONT-SIZE: 9px
}
.fn UL {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; LIST-STYLE-POSITION: outside; =
BACKGROUND: url(/public/css/hr.gif) no-repeat left top; PADDING-BOTTOM: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none
}
.fn LI {
	DISPLAY: block; MARGIN-BOTTOM: 5px; LINE-HEIGHT: 2.5ex; PADDING-TOP: =
5px; TEXT-ALIGN: left
}
.fn LI A:link {
	FONT-SIZE: 11px
}
.fn LI A:visited {
	FONT-SIZE: 11px
}
.formlc {
	CLEAR: none; BORDER-RIGHT: #99adc2 1px solid; PADDING-RIGHT: 5px; =
BORDER-TOP: #99adc2 1px solid; MARGIN-TOP: 15px; PADDING-LEFT: 5px; =
PADDING-BOTTOM: 5px; BORDER-LEFT: #99adc2 1px solid; MARGIN-RIGHT: 10px; =
PADDING-TOP: 5px; BORDER-BOTTOM: #99adc2 1px solid; BACKGROUND-COLOR: =
#eff4f9
}
.groupboxlist {
	CLEAR: none; BORDER-RIGHT: #ccd6e0 1px solid; BORDER-TOP: #ccd6e0 1px =
solid; MARGIN-TOP: 15px; FLOAT: left; BORDER-LEFT: #ccd6e0 1px solid; =
WIDTH: 200px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: #ccd6e0 1px solid; =
BACKGROUND-COLOR: #ffffff
}
.groupboxlist .groupboxheader {
	FONT-WEIGHT: bold; FONT-SIZE: 9pt; COLOR: white; BORDER-BOTTOM: #889db2 =
1px solid; BACKGROUND-COLOR: #335c85
}
.groupboxboxright {
	CLEAR: right; BORDER-RIGHT: #ccd6e0 1px solid; BORDER-TOP: #ccd6e0 1px =
solid; MARGIN-TOP: 15px; FLOAT: right; MARGIN-LEFT: 10px; BORDER-LEFT: =
#ccd6e0 1px solid; WIDTH: 250px; BORDER-BOTTOM: #ccd6e0 1px solid; =
BACKGROUND-COLOR: #ffffff
}
.groupboxboxright .groupboxheader {
	FONT-WEIGHT: bold; FONT-SIZE: 9pt; COLOR: white; BORDER-BOTTOM: #889db2 =
1px solid; BACKGROUND-COLOR: #335c85
}
.groupboxlistleft {
	CLEAR: left; BORDER-RIGHT: #ccd6e0 0px solid; BORDER-TOP: #ccd6e0 0px =
solid; MARGIN-TOP: 15px; FLOAT: left; BORDER-LEFT: #ccd6e0 0px solid; =
WIDTH: 250px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: #ccd6e0 0px solid; =
BACKGROUND-COLOR: #ffffff
}
.groupboxlistleft .groupboxheader {
	DISPLAY: none
}
.groupboxlistleft {
	BORDER-TOP: #ccd6e0 0px solid
}
.groupboxlistright {
	CLEAR: none; BORDER-RIGHT: #ccd6e0 0px solid; BORDER-TOP: #ccd6e0 0px =
solid; MARGIN-TOP: 15px; FLOAT: right; BORDER-LEFT: #ccd6e0 0px solid; =
WIDTH: 300px; MARGIN-RIGHT: 10px; BORDER-BOTTOM: #ccd6e0 0px solid; =
BACKGROUND-COLOR: #ffffff
}
.groupboxlistright .groupboxheader {
	DISPLAY: none
}
.groupboxlistright {
	BORDER-TOP: #ccd6e0 0px solid
}
.groupboxlc {
	CLEAR: none; BORDER-RIGHT: #b4bada 1px solid; PADDING-RIGHT: 2px; =
BORDER-TOP: #b4bada 1px solid; MARGIN-TOP: 15px; PADDING-LEFT: 2px; =
FLOAT: left; PADDING-BOTTOM: 2px; BORDER-LEFT: #b4bada 1px solid; WIDTH: =
300px; MARGIN-RIGHT: 10px; PADDING-TOP: 2px; BORDER-BOTTOM: #b4bada 1px =
solid; BACKGROUND-COLOR: #eceef6
}
.groupboxlc .groupboxitemtitle A {
	BACKGROUND-COLOR: #eceef6
}
.groupboxlc .groupboxitemcontent .text A {
	BACKGROUND-COLOR: #eceef6
}
.groupboxlc .groupboxitemcontent A {
	BACKGROUND-COLOR: #eceef6
}
.groupboxlc .groupboxheader {
	FONT-WEIGHT: bold; FONT-SIZE: 9pt; COLOR: white; BACKGROUND-COLOR: =
#264f95
}
.groupboxlc .attachmenttitle {
	FONT-WEIGHT: normal
}
.contentheader {
	FONT-WEIGHT: bold; FONT-SIZE: 9pt; COLOR: white; BORDER-BOTTOM: #889db2 =
1px solid; BACKGROUND-COLOR: #335c85
}
.groupboxlw {
	BORDER-RIGHT: #6d7cb3 1px solid; BORDER-TOP: #6d7cb3 1px solid; =
BORDER-LEFT: #6d7cb3 1px solid; BORDER-BOTTOM: #6d7cb3 1px solid; =
POSITION: relative; TOP: 0px
}
.groupboxlwnoline {
	CLEAR: none; FLOAT: left; MAX-WIDTH: 31%; MARGIN: 0px 10px 10px 0px; =
WIDTH: 31%; POSITION: relative; TOP: 0px
}
.groupboxlw {
	CLEAR: none; FLOAT: left; MAX-WIDTH: 31%; MARGIN: 0px 10px 10px 0px; =
WIDTH: 31%; POSITION: relative; TOP: 0px
}
.groupboxlwnoline .groupboxheader {
	DISPLAY: none
}
.groupboxlwnoline .groupboxitem .groupboxitemtitle {
	DISPLAY: none
}
.groupboxlwnoline .groupboxitem {
	BORDER-TOP-WIDTH: 0px; BORDER-LEFT-WIDTH: 0px; BORDER-BOTTOM-WIDTH: =
0px; BORDER-RIGHT-WIDTH: 0px
}
.groupboxitemdate {
	DISPLAY: none
}
.groupboxlw .groupboxheader {
	FONT-WEIGHT: bold; FONT-SIZE: 9pt; COLOR: white; BORDER-BOTTOM: #6d7cb3 =
1px solid; BACKGROUND-COLOR: #264f95
}
.groupboxlw .attachmenttitle {
	FONT-WEIGHT: normal
}
.groupboxwhitemedium {
	CLEAR: none; MARGIN-TOP: 15px; FLOAT: left; WIDTH: 50%; MARGIN-RIGHT: =
10px; BACKGROUND-COLOR: #ffffff
}
.groupboxwhitemedium .groupboxheader {
	DISPLAY: none
}
.groupboxwhitewithdate {
	CLEAR: none; MARGIN-TOP: 15px; FLOAT: left; WIDTH: 99%; MARGIN-RIGHT: =
10px; BACKGROUND-COLOR: #ffffff
}
.groupboxwhitewithdate .groupboxitemdate {
	DISPLAY: inline
}
#sitemapsection {
	PADDING-BOTTOM: 25px; WIDTH: 98%
}
#titlesection {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: 0px =
0px 9px; WIDTH: 100%; PADDING-TOP: 0px; BORDER-BOTTOM: #848fc0 1px solid
}
#contact {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
#disclaimer {
	PADDING-RIGHT: 0px; PADDING-LEFT: 10px; PADDING-BOTTOM: 0px; =
PADDING-TOP: 0px
}
.inputTable {
	PADDING-BOTTOM: 30px
}
.inputTableRow {
	PADDING-BOTTOM: 5px
}
.inputTableLabel {
	PADDING-BOTTOM: 5px
}
.inputTableData {
	PADDING-BOTTOM: 5px
}
HTML > BODY #contentsection {
	MIN-HEIGHT: 100%; WIDTH: 100%; HEIGHT: 100%
}
.comments {
	CLEAR: both
}
.recentitems {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; PADDING-BOTTOM: 0px; MARGIN: =
0px; PADDING-TOP: 0px; LIST-STYLE-TYPE: none; marker-offset: 0
}
.countryprofileseven {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 3px; WIDTH: =
800px; PADDING-TOP: 0px
}
.countryprofilesodd {
	PADDING-RIGHT: 6px; PADDING-LEFT: 6px; PADDING-BOTTOM: 3px; WIDTH: =
800px; PADDING-TOP: 0px
}
.countryprofileseven {
	BACKGROUND-COLOR: #ffffff
}
.countryprofilesodd {
	BACKGROUND-COLOR: #f6f5f5
}
TABLE.csstab1 {
	BORDER-RIGHT: #6d7cb3 1px solid; BORDER-TOP: #6d7cb3 1px solid; MARGIN: =
1em 0px 0px; BORDER-LEFT: #6d7cb3 1px solid; WIDTH: 780px; =
BORDER-BOTTOM: #6d7cb3 1px solid; BORDER-COLLAPSE: collapse
}
TABLE.csstab2 {
	BORDER-RIGHT: #6d7cb3 1px solid; BORDER-TOP: #6d7cb3 1px solid; MARGIN: =
1em 0px 0px; BORDER-LEFT: #6d7cb3 1px solid; WIDTH: 780px; =
BORDER-BOTTOM: #6d7cb3 1px solid; BORDER-COLLAPSE: collapse
}
TABLE.csstab1 P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 90%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px
}
TABLE.csstab2 P {
	PADDING-RIGHT: 0px; PADDING-LEFT: 0px; FONT-SIZE: 90%; PADDING-BOTTOM: =
0px; MARGIN: 0px; PADDING-TOP: 0px
}
TABLE.csstab1 TD {
	PADDING-RIGHT: 0.5em; BORDER-TOP: #ccd3e0 1px solid; PADDING-LEFT: =
0.5em; PADDING-BOTTOM: 0.5em; VERTICAL-ALIGN: top; BORDER-LEFT: #ccd3e0 =
1px solid; PADDING-TOP: 0.5em; BACKGROUND-COLOR: #f4f5fa; TEXT-ALIGN: =
left
}
TABLE.csstab2 TD {
	PADDING-RIGHT: 0.5em; BORDER-TOP: #ccd3e0 1px solid; PADDING-LEFT: =
0.5em; PADDING-BOTTOM: 0.5em; VERTICAL-ALIGN: top; BORDER-LEFT: #ccd3e0 =
1px solid; PADDING-TOP: 0.5em; BACKGROUND-COLOR: #f4f5fa; TEXT-ALIGN: =
left
}
TABLE.csstab1 TD.td11 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab1 TD.td12 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab1 TD.td13 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab1 TD.td14 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab1 TD.td15 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab2 TD.td21 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab2 TD.td22 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab2 TD.td23 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab2 TD.td24 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
TABLE.csstab2 TD.td25 {
	COLOR: #f6f7f6; BACKGROUND-COLOR: #264f95
}
.dateLastPublished {
	FONT-SIZE: 90%; COLOR: #435b9d
}

------=_NextPart_000_0000_01C81FB2.6C421910
Content-Type: text/css;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
Content-Location: http://eldd.emcdda.europa.eu/public/templates/genericTemplate/css/hidenavigation.css

#headersection {
	DISPLAY: none
}
#navbar {
	DISPLAY: none
}
#breadcrumbsanduserid {
	DISPLAY: none
}
#leftsidebar {
	DISPLAY: none
}
#footersection {
	DISPLAY: none
}
#content-wrapper {
	FLOAT: left
}
.groupboxwhite {
	FLOAT: none
}
.groupboxes {
	FLOAT: none; WIDTH: 100%
}
.groupboxlwnoline {
	FLOAT: none; WIDTH: 100%
}
.groupboxheader {
	FLOAT: none; WIDTH: 100%
}
.groupboxitem {
	FLOAT: none; WIDTH: 100%
}
.groupboxitemtitle {
	FLOAT: none; WIDTH: 100%
}
.groupboxitemdate {
	FLOAT: none; WIDTH: 100%
}
.groupboxitemcontent {
	FLOAT: none; WIDTH: 100%
}

------=_NextPart_000_0000_01C81FB2.6C421910--

